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Diabetes mellitus has been known since antiquity. Detailed descriptions 
of the disease in two books (Charaka Samhita and Sushruta Ayurveda) 
written over 2 000 years ago show that the physicians of ancient India 
were well versed with it. Based on the following extracts taken from 
the translations of the two books, it can be clearly seen that they 
were able to recognise the two classical forms of diabetes mellitus 
that are known today: "That person who passes urine which is exceed-
ingly sweet, cool, slightly viscid, turbid and resembling the juices 
of sugar cane . . . suffers from glycosuria . . . There are two types 
of urinary disorders - one natural due to genetic factors and the other 
due to indiscrete living or dietetic indiscretions. The patient suf-
fering from the former is thin, pale, eats less and drinks too much. . . 
The patient with the latter is usually obese, eats a lot, is stout and 
of sedentary habits and sleeps too much". (Tulloch 1962). 
In the West the first detailed study of diabetes mellitus by Aretaeus 
of Cappadocia (2nd Century A.D.) appeared to be of the juvenile onset 
type. It was the only kind generally known right up to the 17th century. 
With the recognition of maturity onset diabetes occurring in the middle 
or older age group, it was believed that although juvenile onset 
diabetes (JOD) and maturity onset diabetes (MOD) presented in different 
ways, they represented gradations or variants of the same basic disease 
with quantitative differences in insulin deficiency (Marble 1971, 
Oakley et al 1973). This concept of diabetes, viz: that it was a 
homogenous entity, appeared to be supported by the observations that 
in both types of diabetes the same complications are found. 
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However, in recent years it has been clearly established that diabetes 
mellitus represents a heterogenous group of disorders with glucose 
intolerance being the common denominator. Unequivocal evidence in 
favour of such a concept includes: 
1. The existence of more than 30 distinct genetic disorders with 
glucose intolerance as a feature (Rimoin 1976; Rimoin and Schrmke 
1971). 
2. Ethnic variability in prevalence and clinical features (Rimoin 
1969; Rimoin and Schimke 1971). 
3. Clinical variability between ketosis-prone, insulin-dependent 
juvenile onset diabetes and obese, non ketosis-prone, insulin 
resistant adult onset diabetes (Rotter and Rimoin 1979). 
4. Genetic heterogeneity in animal models (Herberg and Coleman 1977; 
Stauffacher et al 1976). 
5. Genetic studies showing JOD and MOD to be distinct entities 
(Barnett et al 1981; Cudworth and Woodrow, 1976; MacDonald 1974; 
Nerup et al 1976; Pyke and Nelson, 1976; Simpson 1976; 
Tattersall and Pyke 1972). 
Thus reference to diabetes mellitus as a homogenous entity was no 
longer tenable. 
Since 1960 when Fajans recognised a group of young patients showing 
the typical pattern of maturity onset type diabetes, the concept that 
the disease in the young is also a heterogenous entity steadily gained 
ground. Although occasionally references to such cases can be found in 
the literature dating back to 1910 (Tattersall 1974), it was only in 
1965 that maturity onset type diabetes in the young (MODY) was docu-
mented as a distinct entity separate from classical JOD (Fajans and 
Conn 1965). Subsequently several others presented unequivocal data in 
support of the existence of such a disease pattern in the young 
(Johansen, 1973 : Tattersall, 1974). Thus it was concluded that the 
classification of JOD or MOD on the basis of age of onset could no 
longer be justified, because either disease can be recognised at any 
age. Moreover age of onset describes the onset of symptoms and not to 
the onset of the metabolic abnormality which in the case of MOD may be 
present for years before being recognised (Fajans et al 1978; National 
Diabetes Data Group 1979) . 
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In terms of the strong family history and pattern of insulin responses, 
MODY appeared to be akin to the classical maturity type of diabetes 
seen in the middle aged and elderly, (Fajans et al 1978). However, 
in addition to an earlier age of onset, the relatively low prevalence 
of obesity (Fajans et al 1976) and the paucity of complications were 
distinct differences (Fajans et al 1976). 
Biochemical studies have shown that, unlike typical JOD where an 
absolute deficiency of insulin is a consistent finding (Block et al 
1972; Block et al 1973; Parker et al 196-8) MODY is characterised by a 
wide spectrum of insulin responses which may remain unchanged for many 
years (Fajans et al 1978). 
Perhaps the major advances in elucidating the pathogenesis of juvenile 
onset diabetes and delineating it as an entity distinct from MOD or 
MODY have come from studies on the associations between insulin depen-
dent diabetes mellitus (JOD) and the HLA system. A clear relationship 
has been established between JOD and HLA B8, B15, B18, DW3 and DW4 in 
white Caucasians (Cudworth and Woodrow 1975; Nerup et al 1974a) 
Studies in the Japanese (Nakao et al 1977) and American blacks(Duquesnoy 
et al* 1979), have highlighted differences in the specific allelic 
associations among these ethnic groups. 
Research on other aspects of immunology has gone a long way in throwing 
further light on the pathogenesis of JOD. The presence of islet cell 
antibodies in a large proportion of juvenile onset diabetic patients at 
the onset of the illness underlined the importance of autoimmunity as 
an aetiological factor (Bottazzo et al 1974). The demonstration of 
cell-mediated immunity to pancreatic antigen in such patients has lent 
further support to this hypothesis (MaCuish et al 1975; Nerup et al 1974b) 
Whilst it is evident that tremendous advances have been made in recent 
years in our understanding of diabetes in the young, most of the pub-
lished data relate to the disease in White Caucasians. Studies in 
young Africans and Indians have highlighted many unusual patterns of 
diabetes in these people. Thus J-type diabetes occurring in lean 
ketosis - resistant patients and first described in Jamaica but later 
18 
in other tropical countries and the Z-type diabetes associated with 
malnutrition and pancreatic calcification and common in Uganda and 
certain parts of India came to be regarded as distinct forms of 
diabetes grouped together as tropical diabetes and different from 
the disease pattern seen in temperate climates (Tulloch 1962; West 
1978). 
Typical MOD, JOD and a variety of insulin independent diabetes occuring 
in young people (Campbell 1960, 1963) have all been reported in South 
Africa. JOD appears to be uncommon in the African population (Jackson 
1978) with apparently no cases having been reported with onset under 
age 14 (Seftel 1964, West 1978). On the other hand, typical JOD has 
been said to be extremely rare in Indians (Jackson 1978). Non insulin-
dependent diabetes in the young (MODY), however, appears to be common 
among Indians (Campbell 1960; Jackson 1978). 
Two preliminary studies on IDDM and NIDDM in Africans and Indians in 
Natal (Asmal et al 1981 a; Asmal et al 1981 b) focussed on the hetero-
geneity of diabetes mellitus in these two populations and have high-
lighted their distinctiveness from the so called J-type diabetes with 
which they have been recently linked (McMillan and Geevarghese 1979). 
Notwithstanding details of the clinical, biochemical and immunological 
aspects of diabetes mellitus in these population groups are scanty. 
Studies of diabetes mellitus and the HLA system have introduced a new 
field for relating the disease to HLA antigens in these population 
groups. Such data could determine whether there are any specific 
associations between JOD and the HLA system in Africans and Indians 
and whether the absence of any such relationship with MOD or MODY, as 
observed in white Caucasians, (Christy et al 1979; Nelson and Pyke 
1975) was also true of other groups. 
These major advances in our understanding of diabetes mellitus, parti-
cularly in the young, have highlighted the need for a proper evaluation 
of the various aspects of the disease in the young African and Indian 
patient seen in this subtropical setting. Such a study would permit 
an inter-racial comparison of the diabetic syndrome and at the same 
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time define the relative frequencies of IDDM and NIDDM in the young 
and the possible relationship this might have with tropical diabetes 
mellitus. It will also provide a unique opportunity for carrying out 
observations on two population groups whose relatives living in other 
countries have shown certain unusual types of diabetes peculiar to the 
tropics. 
The present study was thus designed to investigate African and Indian 
diabetic patients with age of onset under 35 years and duration of 
disease greater than a year, and obtain a detailed clinical evaluation 
of their disease with additional focus on biochemical accompaniments 
(insulin, C-peptide, other hormones and glycosylated haemoglobin) and 
certain factors of aetiological importance (HLA and islet cell anti-
bodies) . 
It is envisaged that such an approach will help to define the respective 
patterns of diabetes in young Africans and Indians and bring to light 
any distinct clinical, biochemical or immunological features that may 
have a bearing on the pathogenesis of the disease or its complications 
in each of the race groups. 
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CHAPTER II 
MATERIAL AND METHODS 
POPULATIONS- STUDIED 
A total number of 236 diabetic patients with onset of diabetes mellitus 
under the age of 35 were studied. They comprised 115 Africans and 121 
Indians. 
The African patients were almost exclusively of Zulu descent and have 
lived in Natal for many centuries. The vast majority came from a poor 
socio-economic background and were either illiterate or semi-literate. 
The Indian patients were descendants of people who left the Indian sub-
continent towards the latter half of the last century. They comprise 
two ethnic subgroups, viz: the Aryans and the Dravidians, whose pre-
decessors came from North and South India respectively (Mistry 1965). 
The vast majority of the Indians studied were of a low socio-economic 
status, which, however, was somewhat better than that of the Africans. 
Their degree of literacy also was better than that of the latter. 
The diabetics were all patients of King Edward VIII Hospital in Durban. 
They were assessed regularly by the author himself at the Diabetic 
Clinic of that hospital. Informed consent was obtained from all 
patients in whom metabolic studies were done. 
The normal subjects who underwent metabolic studies were, in general, 
medical students who appreciated the research nature of the studies and 
were able to provide informed consent. They were all healthy and denied 
suffering from diabetes or any other medical disorder. At the time of 
study they showed no evidence of recent weight loss and were consuming 
their normal diets. 
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CLASSIFICATION AND DIAGNOSIS 
As recently as 1978 there was no general agreement on the classification 
of diabetes mellitus based on either aetiology or clinical features, in 
spite of accumulating evidence suggesting that the disease was a hetero-
genous entity. Thus it proved difficult to determine the epidemiology 
of the different types of diabetes and to assess the impact of the 
disease and its complications (National Diabetes Data Group 1979). 
In order to provide a uniform framework in which to conduct clinical 
and epidemiologic research, the Expert Committee on Diabetes of the 
WHO has proposed a new classification of diabetes mellitus based on the 
recommendations of the Rational Diabetes Data Group (1979). It is hoped that 
this classification, shown in Table 1, will be able to provide more 
meaningful and comparative data on the scope and impact of the various 
forms of diabetes. 
In the present study the same classification has been used. Thus 
patients have been classified as insulin dependent (IDDM) or non-
insulin dependent (NIDDM) on the basis of the criteria laid down in 
Table 1. Patients with secondary diabetes, whether due to pancreatic 
disease, hormonal abnormalities, drugs or genetic syndromes have been 
excluded from this study. In addition patients with excess ethanol 
intake were also excluded. 
Diagnosis of diabetes mellitus was based on the revised criteria recom-
mended by the Expert Committee on Diabetes of the WHO, shown in Table 
2. However, instead of the 75 gm glucose load as recommended, a 50 gm 
load was mainly used in the patients, because most of them had had 
diabetes mellitus long before the revised criteria appeared and this 
had been the method of doing a glucose tolerance test (GTT) at -King 
Edward- VIII Hospital until recently. 
Based on the classification shown in Table 1, 133 patients (92 Africans, 
41 Indians) were found to have IDDM and 103 (23 Africans, 80 Indians) 
NIDDM. All patients had been fallowed up for at least 12 months after 
diagnosis of diabetes mellitus. H.L.A. studies were 
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TABLE 
CLASSIFICATION OF DIABETES MELLITUS AND OTHER CATEGORIES OF GLUCOSE INTOLERANCE 
(From the National Diabetes Data Group 1979) 
Class Former terminology Associated factors Clinical characteristics Diagnostic criteria 
Clinical Classes 
DIABETES MELLITUS (DM) 
Insulin-dependent type 
(IDDM), Type I. 
Noninsulin-dependent 
types (NIDDM) Type II. 
Other types, including 
diabetes mellitus, as-
sociated with certain 
conditions and syn-
dromes: 
1. Pancreatic disease 
2. Hormonal 
3. Drug or chemical in-
duced 
A. Insulin receptor ab-
normalities 
5. Certain genetic syn-
dromes 














logy suggest genetic and 
environmental or acqui-
red factors, associatior 
with certiain HLA types, 
and abnormal immune re-
sponses, including auto 
immune reactions. 
There are probably mul-
tiple etiologies for 
this class, the common 
outcome being derange-
ment of carbohydrate 
metabolism. Evidence on 
familial aggregation of 
diabetes implies gene-
tic factors, and this 
class includes diabetes 
presenting in children 
and adults in which 
autosomal dominant in-
heritance has been 
clearly established 
(formerly termed the 
MODY type, maturity-
onset diabetes in the 
young). Environmental 
factors superimposed on 
genetic susceptibility 
are probably involved in 
the onset of the NIDDM 
types. Obesity is sus-
pected as an etiologic 
factor and is recommen-
ded as a criterion for 
dividing NIDDM into two 
subclasses, according to 
the presence or absence 
of obesity. 
This subclass contains a 
variety of types of dia-
betes, in some of which 
the etiologic relation-
ship is known (e.g. dia-
betes secondary to pan-
creativ disease, endo-
crine disease, or ad-
ministration of certain 
drugs). In others, an 
etiologic relationship 
is suspected because of 
a higher frequency of 
diabetes with a syndrome 
or condition (e.g. a num-
ber of the genetic syn-
dromes). See Table 3 tor 
a list of these condi-
tions and syndromes. 
Persons in this subclass 
are dependent on injected 
insulin to prevent keto-
sis and to preserve life, 
although there may be 
pre-ketotic, noninsulin-
dependent phases in the 
natural history of the 
disease. In the prepon-
derance of cases, onset 
is in youth, but IDDM 
may occur at any age. 
Characterized by insul-
inopenia. Islet cell 
antibodies are frequently 
present at diagnosis in 
this type. 
Persons in this subclass 
are not insulin-depen-
dent or ketosis-prone, 
although they may use 
insulin for correction 
of symptomatic or per-
sistent hyperglycemia 
and they can develop 
ketosis under special 
circumstances, such as 
episodes of infection or 
stress. Serum insulin 
levels may be normal, 
elevated, or depressed. 
In the preponderance of 
cases, onset is after 
age 40, but NIDDM is 
known to occur at all 
ages. About 60-90% of 
NIDDM subjects are obese 
and constitute a subtype 
of NIDDM; in these pat-
ients, glucose tolerance 
is often improved by 
weight loss. Hyperin-
sulinemia and insulin 
resistance characterize 
some patients in this 
subtype. 
In addition to the pre-
sence of the specific 
condition or syndrome, 
diabetes mellitus is 
also present. 
Diagnosis of diabetes 
in adults should be 
based on: 
1) unequivocal eleva-
tion of plasma glucose 
concentration together 
with the classical symp-
toms of diabetes, 
or 2) elevated fasting 
plasma glucose concen-
tration on more than 
one occasion, 
or 3) elevated plasma 
glucose concentration 
after an oral glucose 
challenge on more than 
one occasion. 
Diagnosis of diabetes 
in children requires 
either 1) or 2) and 
3). 
See Table 2 for diag-
nostic plasma glucose 
standards. 
In order to place an 
individual in the 
subclass Other Types, 
two diagnostic deter-
minations must be 
made, the presence of 
diabetes (as described 
above) and the pre-
sence of the associa-




CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS 
(From the National Diabetes Data Group) 
Any one of the following are considered diagnostic of diabetes: 
A. Presence of the classic symptoms of diabetes, such as polyuria, 
polydipisia, ketonuria and rapid weight loss, together with gross and 
unequivocal elevation of plasma glucose. 
B. Elevated fasting glucose concentration on more than one occasion:-
venous plasma 5 140 mg/dl (7.8 mmol/L) 
venous whole blood 5 120 mg/dl (6.7 mmol/L) 
capillary whole blood ^ 120 mg/dl (6.7 mmol/L) 
If the fasting glucose concentration meets these criteria, the OGTT is 
not required. Indeed, virtually all persons with FPG > 140 mg/dl will 
exhibit an OGTT that meets or exceeds the criteria in C. below. 
C. Fasting glucose concentration less than that which is diagnostic of 
diabetes (B. above), but sustained elevated glucose concentration during 
the OGTT on more than one occasion. Both the 2-h sample and some other 
sample taken between administration of the 75-g glucose dose and 2 h 
later must meet the following criteria:-
venous plasma S 200 mg/dl (11.1 mmol/L) 
venous whole blood S 180 mg/dl (10.0 mmol/L) 
capillary whole blood S 200 mg/dl (11.1 mmol/L) 
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done on an additional 15 Indians with IDDM. However, since a 
full clinical examination was not carried out on them, they have been 
excluded from the rest of the study. 
Of the patients grouped under the category of NIDDM, 24 (19 Indians, 
5 Africans) initially presented as such but later required insulin for 
control of symptoms. 
Five of the insulin dependent-^diabetic patients (4 Africans, 1 Indian) 
did not show ketonuria at any time even in the absence of insulin 
therapy, although they needed insulin for control of symptoms. The 
mean age of onset of diabetes mellitus in these patients was 27.5 
years (range 23 - 30) and the mean duration of disease 4.3 years 
(range 2 - 7 ) . They had a mean body weight of 61 kg (range 52 - 67), 
whilst the percentage ideal body weight in each of the 2 patients over 
the age of 25 was 96. The mean daily insulin requirement was 43 Iu 
(range 28 - 44) or 0.73 Iu/Kg. 
To all intents and purposes they could be categorised under the 
umbrella of J-type diabetes, except that their daily insulin require-
ments were not particularly high as has been found elsewhere (Hugh-
Jones 1955, Kar and Tripathy 1967). Since in this study they only 
accounted for 2.4% and 3.2% of all the young African and Indian insulin 
dependent diabetic patients respectively, J-type diabetes appears to be 
rare in these population groups. 
Although the classification shown in Table 1 does not take into account 
J-type diabetes, West (1979) has suggested that it can be regarded as 
a subgroup of insulin-dependent diabetes. Therefore the 5 patients 
with this type of diabetes have been included under the IDDM category. 
Since the Diabetic Clinic at King Edward VIII Hospital where this study 
was undertaken serves mainly as a consultative clinic seeing to problem 
cases referred from the general medical clinics of this and other hos-
pitals in and around Durban, the patients seen there represent a select 
group of subjects. Thus the young patients seen do not represent the 
true proportions of the patterns of diabetes present in the respective 
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populations. Therefore in order to obtain an estimate of the relative 
frequencies of IDDM and NIDDM in the young, preliminary surveys of the 
pattern of diabetes at the referring clinics and hospitals were carried 
out. Two surveys were performed on Indian and one on African patients. 
They involved examination of the clinical case records of all diabetics 
seen at the referral centres over a four week period and analysis of 
data on age, sex, duration of diabetes and type of therapy. 
In a survey of 247 African diabetic patients, 21 had IDDM, which there-
fore accounted for 10.1% of the total diabetic population. Of the 
patients under age 35, 84% were insulin-dependent. (Addendum I). 
Combined data from 2 surveys showed that out of a total of 2 420 Indian 
diabetic patients 267 were under the age of 35 and of these 89% were 
categorised as non-insulin dependent (NIDDM). Patients with IDDM 
accounted for only 1.1% of the total Indian diabetic population. (Addendum I). 
METHODS 
All the patients described in this study had the following data recorded:-
1. Sex, age, height, weight. 
2. Percentage ideal body weight in patients over 25, calculated as 
follows: Body weight of patient 1nf) 
Ideal body weight for a medium framed patient of 
similar height (Diem and Lentner 1970) 
3. Percentile for body weight and height in patients under 18 years. 
4. Age at diagnosis and month of onset. 
5. Duration of diabetes. 
6. Family history of diabetes. 
7. Mode of presentation. 
8. Presence or absence of ketosis. 
In addition, a full physical examination was carried out on each 
patient, paying particular attention tor-
Blood pressure; 
Presence or absence of peripheral pulses; 
Abnormalities of peripheral or autonomic nerve function; 
The eyes for cataracts or evidence of retinopathy; 
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Nephropathy; 
Ischaemic heart disease. 
Peripheral Neuropathy 
The following criteria were used to diagnose peripheral neuropathy:-
1. Symptoms of neuropathy such as pain, paraesthesia, hyperaesthesia, 
foot drop. 
2. Loss of touch, pain, position or vibration sense. 
3. Absent reflexes. 
Patients were considered to have diabetic peripheral neuropathy if these 
criteria were present in the absence of other common disorders associated 
with neuropathy. 
Autonomic Neuropathy 
This was diagnosed on the basis of :-
1. Impotence. 
2. Heart rate response to standing i.e., absence of a tachycardia on 
changing from the horizontal to the vertical position. 
3. Postural Hypotension, which is considered to be present if the 
difference between the lying and standing systolic pressure is 
greater than 30 mm Hg (Ewing et al 1973). 
Retinopathy 
Fundal examination was carried out by first instilling a mydriatic in 
each eye and then 30 minutes later examining each fundus for at least 
2 minutes. 
Retinopathy was classified as background if there were microaneurysms, 
exudates or small haemorrhages; or as proliferative if there were large 
haemorrhages, neovascularisation, retinal or vitreous fibrosis or 
retinal detachment. 
Nephropathy 
This was deemed to be present if:-
1. Proteinuria (as measured by Albustix) was found on 3 consecutive 
urine samples, taken on different occasions at least a month apart. 
2. The serum creatanine was elevated. 
In patients showing either of these abnormalities a GFR was done using 
Chromium labelled EDTA. 
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Ischaemic Heart Disease 
This was diagnosed on the basis of:-
1. Symptoms of angina. 
2. Resting ECG changes, viz: ST depression, T wave inversion, LBBB. 
X-Ray Abdomen 
Abdominal radiographs were done on all the patients with IDDM. Only 
two patients, aged 15 and aged 29 and both females, showed calcifica-
tion in the region of the pancreas. Neither patient gave any history 
of alcohol consumption. The younger patient was below the 3rd percen-
tile for height, ketosis prone and could be categorised as Z-type 
diabetes which appears to be associated with malnutrition. (West, 1978). 
Hormonal Levels and Antibody Assays 
Blood samples from patients and normal subjects were collected in the 
mornings and separated within 2 hours. Sera were immediately stored 
in small aliquots at -20 C, until the time of assay. Thus tests were 
carried out on samples that had been thawed once only. 
Tests of Beta Cell Function Using Glucose or Glucagon 
All studies were carried out on overnight fasted subjects. In patients 
with NIDDM who were on long acting sulphonylureas, drug therapy was 
discontinued at least 72 hours before the investigations were performed. 
Patients with IDDM were given no insulin on the morning of the test 
and soluble insulin only on the evening before the test to ensure 
that there would be no residual depot action of long acting insulin. 
"Medican" (R) 16g cannulae were introduced into forearm veins under 
local analgesia and kept patent with 0.9% saline infusions. Basal 
blood samples were taken after a rest period of at least 30 minutes. 
Thereafter, depending on the test, lOOgm glucose dissolved in 200 ml 
of water was administered or glucagon (1 mg) injected intravenously. 
Blood samples for glucose and insulin or C-peptide were then collected 
at varying intervals after the stimuli. 
Plasma glucose was measured by means of an autoanalyser and C-peptide 
(Mallinkrodt Kit) and insulin (Phadebas Kit) by radioimmunoassay. 
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Basal Hormonal and Lipid Profiles 
Blood samples for growth hormone, glucagon, Cortisol, cholesterol and 
triglycerides were taken after an overnight fast. The hormones were 
measured by radioimmunoassay (Pharmaca Diagnostica, Biodata and 
Gamma Coat Kits for growth hormone, glucagon and Cortisol respectively). 
Plasma cholesterol and triglyceride levels were measured enzymatically. 
HLA Studies 
HLA A, B, C and DR specificities were done on the same day as the blood 
samples were taken. A two-stage lymphocytotoxicity test using 180 
antisera was employed to determine HLA A, B and C antigens, whereas 
an extended incubation microlymphocytotoxicity test using B cell 
enriched» T cell depleted lymphocytes was employed to determine HLA 
DR antigens. 
Islet Cell Antibodies and Other Autoantibodies 
Islet cell antibodies, both IGg antibodies (ICA IGg) and complement 
fixing (ICA-Cf), were measured by immunofluoresence using fresh 
pancreas from a blood group 0 cadaver as antigen. Antibodies to 
thyroglobulin and thyroid microsome, to parietal cell and to adrenal 
tissue were also measured by immunofluoresence. 
Immune Complexes 
These were measured by the Raji cell assay and the results quantitated. 
Statistical Analysis 
Means, standard errors, standard deviations, paired and unpaired 
t-tests, X tests and correlation co-efficients were calculated using 
programmes made out for the Hewlett Packard 67 Computer. 
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CHAPTER III 
CLINICAL FEATURES OF INSULIN - DEPENDENT 
DIABETES IN AFRICANS AND INDIANS 
INTRODUCTION 
Published data on the epidemiology, clinical and biochemical features 
of diabetes mellitus in the different racial groups of South Africa 
mostly relate to the disease in adults with maturity-onset diabetes 
(Jackson and Huskisson 1965; Marine et al 1969; Seftel et al 1963) 
Up till 1980 apart from a preliminary survey in Ethiopia on 27 Ethio-
pian juvenile diabetics (Lester 1978), there had been little information 
on the clinical features of IDDM in the young. Typical juvenile onset 
diabetes has been described as extremely rare in the Indian (Jackson 
1978) and "much rarer in Coloured and African than white people" in 
South Africa (Marine et al 1969). It has also been suggested that JOD 
in Southern Africa might be synonymous with the so-called J-type dia-
betes of the Tropics (McMillan and Geevarghese 1979) . 
MATERIALS AND METHODS 
Ninety two African and forty one Indian patients who fulfilled the 
following criteria were selected and studied:-
1. Age at diagnosis under 35 years. 
2. Development of symptoms and/or ketosis in the absence of insulin 
therapy. 
3. Duration of diabetes mellitus greater than two years. 
The following data were recorded from all the patients studied:-
1. Age and month of onset. 
2. Duration of diabetes mellitus. 
3. Mode of onset. 
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4. Family history (first degree relative being defined as mother, 
father, offspring or sibling). 
5. Sex. 
6. Weight, height and percentage desirable weight which was calculated 
thus: Actual Body Weight 1 f._ 
Medium-frame Ideal Body Weight for the same height 
7. Episodes of coma or severe ketoacidosis: diagnosed on the basis of 
hyperglycaemia, impaired consciousness, dehydration, acidotic 
breathing, ketonuria and a serum bicarbonate less than 9 mmol/L, 
(Bradley 1971; Oakley et al 1973). 
In addition, a full physical examination was carried out on each patient. 
Peripheral neuropathy and autonomic neuropathy were assessed on the 
basis of the criteria outlined in Chapter II. Fundal examiantion was 
done after instillation of a mydriatic, (as described in Chapter II). 
Nephropathy was diagnosed on the basis of albuminuria in 3 consecutive 
urine specimens or elevated creatinine levels. Patients in whom either 
of these were positive had measurements of their glomerular filtration 
rate done by means of chromium -labelled EDTA. 
RESULTS 
Results are presented in Tables 1 - 3 and Figures 1 ~ 6 
Age of onset 
Figure 1 illustrates the ages of onset of IDDM in the African and Indian 
patients. The mean age of onset of the disease is lower in the Indian 
patients (mean 17 years) than in the African patients (mean 23.5 years), 
p < 0.025. Only one African patient presented before the age of 5, 
whereas 8 Indian patients presented before this age. 
Sex 
Although in both the African and Indian patients there was a slightly 
higher number of females, the difference was not significant. 
Duration of IDDM 
Figure 2 depicts the pattern of duration of diabetes seen in the 
patients studied. 
TABLE 1 CLINICAL CHARACTERISTICS OF THE PATIENTS WITH IDDM 
Number of patients 
Male : female ratio 
Mean age of onset 
Mean duration of disease 
Mean percentage desirable 
weight 
Family history 
Frequency of onset -
winter : summer 
( )* range 
Africans 
92 





1.3 : 1 
Indians 
41 
17 : 24 




2.3 : 1 
Total 
133 




1.5 : 1 
Figure 1 
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Weight 
Figure 3 depicts the distribution of percentage desirable weights in 
adults with IDDM. The mean percentage desirable weight of the African 
patients (106%) was significantly higher than that of the Indian 
patients (mean 91.5%), p < 0.005. 
Of the patients under the age of 18, 50% of the Africans and 40% of the 
Indians fell within the 10th to the 90th percentile for height, whilst 
31% and 40% respectively fell below the 5th percentile. Figure 4 
illustrates the relationship between duration of diabetes and the per-
centile for height in the insulin-dependent diabetic patients under 
age 18 years. No correlation is seen between growth and duration of 
diabetes. 
In patients under the age of 18, 77% of the Africans and 60% of the 
Indians fell within the 10th to the 90th percentile for weight whilst 
14% and 30% respectively fell below the 5th percentile. Figure 5 
illustrates the relationship between duration of diabetes and the 
percentile for weight in insulin-dependent diabetic patients under 18 
years. No correlation is seen. 
Family History 
Twelve (13%) African patients gave a family history of diabetes affect-
ing a first degree relative. It was of the non-insulin dependent type in 
all the affected relatives except one. In contrast a family history of 
diabetes affecting a first degree relative was present in 22 Indian 
patients (54%), in 3 of whom the affected relatives had IDDM. One of 
the patients had a first cousin suffering from IDDM. 
Seasonal Variation in the Onset of IDDM 
Figure 6 illustrates the frequency of cases of IDDM in relation to the 
month of onset of the disease in those patients (73 Africans and 33 
Indians) in whom a reliable history was obtained. There appears to be 
a slightly higher rate of onset in winter than summer (1.5 : 1) if 
April to September are taken as the winter months. The winter pre-
dominance appears to be much more marked among Indians (2.3 : 1) than 
among Africans (1.3 : 1). 
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Figure 4. 
THE RELATIONSHIP BETWEEN DURATION OF IDDM AND PERCENTILE FOR HEIGHT 
















Duration of IDDM in years 
37 
Figure 5. 
THE flELATIONSHIP BETWEEN DURATION OF IDDM AND PERCENTILE FOR WEIGHT 
IN PATIENTS UNDER 18YEARS OF AGE 
• Africans 
o Indians 
r=-0.11 p N.S. 
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Presentation 
All the patients except 9 presented acutely, with symptoms of polyuria, 
polydipsia, tiredness, loss of weight and polyphagia being predominant 
and present for a short duration. The onset was fulminating in 15 
patients, who presented in ketoacidotic coma. One patient presented 
with lactic acidosis without any previous history of diabetes or in-
gestion of alcohol or biguanides. Of the 9 patients (5 African and 
4 Indian) with a subacute onset 5 presented with an abscess, whilst in 
2 of them the disease was discovered after urine specimens showed gly-
cosuria during routine medical examinations. Both the latter patients 
were under age 19 and dependent on insulin "ab initio". Ten of the 15 
patients who had a severe onset of IDDM were under the age of 20. 
Complications: 
These are shown in Tables 2 and 3. 
Ketoacidotic coma 
There were 75 patients who developed ketoacidotic coma on one or more 
occasions. This complication was the presenting feature of the disease 
in almost 30% of such patients. Omission of insulin was the precipi-
tating factor in 44% of the patients who developed ketoacidotic coma. 
Whilst almost 70% of the African patients manifested with ketoacidotic 
coma on one or more occasions, just over 50% of the Indian patients 
developed this complication. In 56% of the African patients omission 
of insulin was a contributory factor whereas it was responsible in only 
26% of the Indian patients. 
Neuropathy 
Neuropathy was a common complication. The mean duration of the disease 
in all the patients with peripheral neuropathy was 5,8 years. Indian 
patients show a slightly longer mean duration (6 years) than the African 
patients (5,6), but the difference was not significant. 
The duration of IDDM was less than a year in 50 per cent of the African 
patients manifesting with this complication. One African patient and 
4 Indian patients had symptoms of peripheral neuropathy. An absent ankle 
jerk was present in 20 per cent of the patients and in 40 per cent of 
these patients IDDM was present for less than 2 years. Impairment of 
vibration sense and of joint position was found in 3 patients. 
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TABLE 2 PREVALENCE OF COMPLICATIONS IN PATIENTS WITH IDDM 
Complications 
Ketoacidosis 














































































Abnormalities of these modalities of sensation were always associated 
with absent reflexes. 
Autonomic Neuropathy 
Impotence was present in seven patients, two of whom manifested with 
this complication at the onset of the disease. Four patients showed 
evidence of autonomic neuropathy on the basis of the screening tests 
used. One of them also showed other florid features of autonomic 
neuropathy viz: gastric and oesophageal atony, impotence, bladder 
atony and intractable diarrhoea. As expected he had peripheral neuro-
pathy which has been shown to be an invariable accompaniment of auto-
nomic neuropathy (Campbell et al 1975; Whalen et al 1969; Wheeler 
and Watkins 1973). 
Retinopathy 
Background retinopathy was found in 14% of the African and 22% of the 
Indian diabetic patients. The mean duration of the disease was similar 
in both racial groups. In 2 of the African patients retinopathy was 
discovered at the onset of the disease. Of the 7 African patients who 
had IDDM for more than 10 years, all showed evidence of retinopathy, 
whilst of the 8 Indian patients with a similar duration of disease, 5 
showed this complication. In patients who had IDDM for less than 10 
years only 7% of the Africans and 12,5% of the Indians showed evidence 
of retinopathy. Only one patient had proliferative retinopathy. 
Nephropathy 
Based on the criteria used in this study, 6 patients were found to 
have nephropathy. The mean duration of IDDM was 15.5 years (range 
12 - 27 years). Two patients had persistent albuminuria in the 
presence of a normal creatinine concentration. One of them who died 
of acute suppurative pyelonephritis and renal papillary necrosis had 
typical features of diabetic nephropathy on histological examination 
of autopsy tissue. All 6 patients with nephropathy also had retino-
pathy, which has been found to be invariably associated with this 
complication (Bjerkelund 1951). The mean GFR, which could be done 
in 4 patients, was 52 ml/minute (range 35 - 75 ml). 
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Triopathy 
Nephropathy, retinopathy and neuropathy were present together in 3 
patients. The mean duration of disease in these patients was 11.3 years. 
Hypertension 
Hypertension was seen in 6 patients. Whilst it was associated with 
nephropathy in both the Indian patients, such a relationship was found 
in only 2 of the 4 African patients. 
Cataracts 
Cataracts of gradual onset, the usual form seen in diabetes of long 
duration, was seen in 3 patients, all of whom had the disease for at 
least 10 years. 
Another 4 patients presented with dense subcapsular cataracts after a 
short history of symptoms of diabetes. 
Tuberculosis 
Active pulmonary tuberculosis was present in 6 of the African patients 
(6%) with IDDM. t)nly one Indian patient had this complication. 
Insulin Requirements 
Although the mean insulin requirements were lower in the Indian patients 
(mean 1.20 +^0.10 Iu/kG/day) compared to the African patients (mean 
1.50 +^0.14 Iu/Kg/day) , the difference was not significant. One of 
the African patients required 480 Iu monocomponent insulin daily 
(8.7 Iu/Kg) for stabilisation. 
DISCUSSION 
Studies of rates of prevalence of insulin-dependent diabetes are 
hampered by the fact that as the disorder is infrequent large popu-
lation samples are required and it is difficult to obtain a represen-
tative sample when such large numbers are needed (West 1978). Table 3 
illustrates approximate rates of prevalence in most of the populations 
where such studies have been done. Because methods of ascertainment 
are not precisely comparable in these populations, differences of 
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Table 4 
















































moderate degree are not necessarily significant. Although the data 
presented are far from complete, it appears that insulin-dependent 
diabetes is a disease affecting people living in northern European 
climates and individuals whose ancestors came from those areas of the 
world. Cahill (1979) expresses similar views, although his conclusion 
that juvenile onset diabetes in the black results from racial admixture 
is somewhat tenuous. Similarly Pyke (1969) observed that typical 
juvenile onset diabetes was uncommon in all non-white racial groups. 
If the overall prevalence of diabetes in the Africans is 0.7% (West 
1978) then IDDM represents 0.07% of the population. The prevalence 
rate in Denmark is considerably higher (0.39%). Comparison whith other 
African populations is not possible because of the unavailability of 
actual data. There is a slightly higher rate among American blacks 
(0.1%), although the difference could be more accentuated if the age 
cut"off point in the latter study was higher than 20. According to 
several workers the prevalence of the disease appears to be inter-
mediate between that seen in whites and that seen in black Africans 
from Africa, (Gorwitz et al 1976; MacDonald 1970; MacDonald 
1980; Rodey et al 1979). 
In contrast IDDM appears to be much less common in Indians, because 
if the overall prevalence of diabetes is taken as 1.8% of the Indian 
population (West 1978), then IDDM represents only 0.018% of the popu-
lation. Such low prevalence rates have also been found in India, 
(Patel et al 1966; Sathe 1973; Visvanathan et al 1966) , whence all 
our Indian patients have their origins. The disease has been found to 
be rare even in Indians of Singapore (Tulloch 1962) and of Fiji (Cassidy 
1967). 
The best-studied series on age of onset of insulin-dependent diabetes 
propably comes from the Joslin Clinic. The disease is rare before the 
age of 5 and thereafter the incidence increases with age reaching a peak 
at age 11 (White and Graham 1971). The maximal frequency for girls is 
at age 10 and for boys at age 13. Similar figures for peak frequency 
have been found in Denmark (Christau et al 1977). In Japan most 
patients were found to present with the disease between the ages of 10 
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and 13 (Mimura 1970). However, Bloom et al 1975, observed a bimodal 
distribution in the age of onset, with a peak at 11 and another in 
the early 20's. Similarly Cudworth et al (1977) found smaller but 
definite peaks between 21 to 23 years and at 5 to 7 years in addition 
to a large peak at age 11. 
Whereas the peak frequency occurred in the third decade in Africans, 
it was in the second decade in the Indian patients , who showed a 
steady peak through all the years (11 - 19), in contrast to the 
sudden sharp rise found in Denmark and America. Crossley and Upsdell 
(1980.) also observed a steady peak during the second decade among 
insulin-dependent diabetic patients in New Zealand. Although 
diabetes may be found in earliest infancy, all studies have shown 
much lower rates in the first 5 years, (West 1978). Only one African 
had an onset under age 5, whilst 8 Indians presented before this age. 
In most studies of IDDM on white Caucasians there have been no 
significant differences in prevalence rates for boys and girls, 
(West 1978). Although in the African and Indian patients, there 
was a slightly higher number of females, the difference was not 
significant. 
Prior to the availablility of long acting insulin poorly controlled 
diabetes was sometimes associated with marked retardation of growth. 
This condition was known as diabetic dwarfism (West 1978) . Recent 
studies have shown that growth and skeletal maturity are normal in 
insulin-dependent diabetics (Birbeck 1972; Weil 1967; White and 
Graham 1971) , and that impairment of growth only occurred with sub-
optimal control (Birbeck 1972). However, Jivani and Rayner (1973) 
did not observe any relationship between rates of growth and degrees 
of control in their diabetic children, who showed subnormal growth 
in the three years following the onset of diabetes. In a group of 
Japanese juvenile diabetic children studied, growth was retarded 
in those who had the disease for more than four years,(West 1978). 
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The fact that up to a third of the African and Indian patients were 
below the 5th percentile for weight suggests that IDDM does retard 
growth in these race groups. However, growth retardation was in-
dependent of duration of diabetes. 
Although considerable confusion, controversy and uncertainty exists 
in regard to the role of heredity in the aetiology of diabetes, it 
is clear that genetic factors are quite important, (West 1978). 
Rosenthal et al (1976) concluded that "diabetes mellitus in man, 
regardless of age of onset, is primarily genetic in origin with 
environmental factors influencing only the time of appearance of the 
disease". Several groups of workers felt that heredity played a 
greater role in the aetiology of insulin dependent diabetes than of 
non-insulin dependent diabetes, (Falcolner 1967; Goodman and 
Chung 1974; Simpson 1969). On the other hand in studies on identi-
cal twins both Gottlieb et al (1974) and Barnett et al (1981) found 
only a fifty percent concordance rate for diabetes in those with 
insulin=dependent diabetes as compared to a rate of almost hundred 
per cent in those pairs in whom diabetes in the index case was of 
the non-insulin dependent type. Thus it appears that the principal 
genetic mechanisms involved are to a substantial degree separate 
for insulin-dependent and non-insulin—dependent diabetes mellitus 
(Barnett et al 1981; Pyke and Nelson 1976). 
The 13% prevalence of a positive family history in Africans is similar 
to that observed by Cudworth et al (1977). A positive family history 
in over 50% of the Indian patients is a most unusual finding when 
cognisance is taken of the fact that many studies have shown a low 
prevalence of positive family histories in patients with IDDM. In 
a study involving 210 parents of juvenile onset diabetic patients in 
Israel only 5 of them were found to have the disease (Cohen et al 
1970). Low rates of a family history of diabetes have also been 
found in Japanese (West 1978), and some tropical countries (Tulloch 
1962; Wicks and Jones 1974). 
Since in this study the relatives of the vast majority of the patients 
had NIDDM, it is difficult to gauge the significance of the results 
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obtained. It is possible though that the gene for NIDDM in some way 
confers an increased susceptibility to IDDM also in the Indian patients; 
whereas in the African patients a different genetic mechanism operates. 
Distinct seasonal patterns in the onset of IDDM have been observed in 
many studies. Higher rates of onset in winter than in summer have been 
found in British and Irish children with IDDM (Bloom et al 1975, Gamble 
and Taylor, 1969) and in American Blacks with juvenile onset diabetes 
(Al-Arif and Strong 1981). Similar observations have been made among 
other white Caucasian populations (Christau et al 1977; Cudworth et 
al 1977; Danowski 1957; White and Graham 1971). However, the rate 
of onset also appeared to be especially common in January in some of 
these studies (Gamble and Taylor 1969; White and Graham 1971). In a 
large series in Massachusetts Gleason et al (1977) could find no 
significant seasonal variation in the onset of IDDM. 
A study highlighting differences in the season of onset of diabetes 
mellitus should include a very large number of patients. Therefore, it 
is very difficult to assess the significance of any differences that 
are found in this study where a reliable history was obtained from 73 
Africans and 33 Indians with IDDM. Nevertheless, if April to September 
are taken as the winter months in Durban, then there is a higher rate 
of onset in winter than in summer, particularly in the Indian patients 
in whom the rate of onset (twice as high in winter as in summer) was 
similar to that observed by Cudworth et al (1977) . 
Insulin-dependent diabetes characteristically presents acutely, although 
in many instances the onset may be subacute or even associated with 
long periods of ill health, (Bloom et al 1975; Cudworth et al 1977). 
The vast majority of the diabetic patients in this study presented 
acutely. 
IDDM with a fulminant onset is more common in children and adolescents 
than in adults (Oakley et al 1973). Thus, as expected, in this study 
only five of the 15 patients whose onset was severe were over the age 
of twenty. 
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Despite the fact that the use of the term complications to describe 
the pathological manifestations of diabetes has now been challenged 
(West 1978), this term has been retained in this study since the 
abandonment of this traditional term has not yet met with widespread 
acceptance. 
Diabetic coma due to ketoacidosis is today largely a preventable dis-
order in which social, economic, administrative and medical factors 
play a role, (West 1978). Whilst improved public education has re-
duced the frequency with which diabetic ketoacidosis marks the onset 
of previously undiagnosed diabetes mellitus, about 8 - 20% of cases of 
ketoacidosis in various series are still due to new cases (Biegelman 
1971; Genuth 1980). In this study, however, almost 30% of those who 
developed ketoacidosis presented with this complication at the onset 
of the disease. Inadequate public education and primary health care 
facilities are probably responsible for such a high rate. 
Discontinuation of insulin therapy and infection used to be the most 
important causes of ketoacidosis in both developed and underdeveloped 
countries (Baker, 1936, Biegeliftah, 1971, Bortz and Spoont 1967; Cohen 
et al 1960; Lester 1980; Thandanand et al 1978). Now, however, 
infection appears to be the main precipitating factor in most of the 
patients with diabetic ketoacidosis seen in the developed countries, 
with omission of insulin accounting for only 4 to 7% of cases. 
(Genuth 1980). Among the patients reported in this study both omission 
of insulin and infection are equally important in precipitating keto-
acidosis. Again inadequate education, poor socioeconomic conditions 
and lack of primary health care facilities are to a large extent re-
sponsible for such a high frequency. 
The reason for the slight but significant difference in the incidence 
of ketoacidosis between the 2 racial groups may be related to the 
relatively better socioeconomic status and educational background of 
the Indian patients. 
Studies of the prevalence of diabetic neuropathy based on clinical 
criteria have yielded varying results because of a inadequate standard-
isation of the criteria and methods of investigation. A prevalence of 
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40% has been reported by Goodman (1955), of 12% by Pirart (1965) and of 
4% by Rundles (1945)• It is rare in children and uncommon in adoles-
cents, occurring more frequently with increasing age, (Oakley et al 
1973). 
Peripheral neuropathy appears to be fairly common in both groups with 
IDDM. Studies in other African and Indian population groups have also 
found a fairly high incidence of diabetic neuropathy (Chuttani and 
Chawla 1974; Osuntokun et al 1971). 
While in the majority of the Indian patients the duration of IDDM was 
more than 5 years, in 50% of the African patients the disease had been 
present for less than a year only. Thus it appears that in addition to 
duration of diabetes, as suggested by Gregersen (1977) other factors 
play a role in the development of neuropathy. An association with 
hyperglycaemia has been noted by Christensen (1973), Pirart (1965) and 
Thomas and Ward (1975). 
Symptoms such as paraesthesia and numbness are the least sensitive 
indices of neuropathy (West 1978). Thus the rarity of symptomatic 
manifestations of this complication is not at all surprising. 
Nilsson et al (1967) studied the significance of the ankle reflex in a 
group with no diabetes. He found an absent reflex in 25% of those over 
the age of 60 and in none under this age. In their young diabetic 
patients (age 20 - 39), 34% showed an absent or partly absent ankle 
jerk. 20% of the patients reported in this study had an absent ankle 
jerk and in over 40% of these patients the disease was present for less 
than 2 years. In the young diabetic patients studied by Nilsson et al 
(1967), 34% of the patients with neuropathy had had diabetes for a 
short duration (mean 1.5 years). 
Some workers have considered an impaired vibration sense to be the 
earliest sign of peripheral neuropathy, (Mouren et al 1966) . However, 
only 2% of the patients reported in this study demonstrated an impaired 
vibration sense. None of the young diabetic patients in the group 
studied by Nilsson et al (1967) showed impaired vibration sense. 
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Although motor function abnormalities such as weakness of the legs and 
foot drop do occur, they are much less common (Faerman et al 1980; Oakley 
et al 1973). None of the patients in this study showed any evidence 
of a motor neuropathy. 
Although autonomic neuropathy depends on the duration of diabetes , 
(Annon 1976; Low et al 1975) , it has also been reported in the early 
stages of juvenile onset diabetes (Faerman et al 1971; Jadzinsky et 
al 1977). 
The commonest manifestation of this form of neuropathy in adult males 
reported in this study was impotence, which is probably the most common 
symptom related to autonomic neuropathy. Its prevalence has been found 
to be up to 50 per cent in various series (McCulloch et al 1980; Rubin 
and Babbott 1958; Rundles 1945; Schoffling et al 1963). It may be 
present without other features of autonomic neuropathy (Ewing et al 
1976). When other signs of autonomic neuropathy are present, impotence 
is almost invariable, (Clarke et al 1979). 
Although the prevalence and natural history of diabetic autonomic 
neuropathy have not yet been clearly elucidated (Clarke et al 1979) it 
is still considered relatively uncommon (Ward 1978). Thus the rare 
occurrence of this complication in this study is not unexpected. 
Retinopathy is a major cause of morbidity in many diabetic patients. 
Although clinically detectable lesions of the retina eventually develop 
in most patients, impairment of vision of varying degrees occurs in 
about 50 per cent of patients with long standing diabetes (West 1978). 
The prevalence of retinopathy appears to vary in different population 
groups, (West 1978). It is rare in young Caucasian diabetic patients 
with duration of diabetes less than 10 years (Kahn and Bradley 1975) 
but common in young Kenyan diabetics whose disease was present for a 
similar duration, (Steel et al 1977) . Low rates have been reported in 
Nigeria even in patients with diabetes of long duration (Osuntokun 
1969), in Congo (Bourgoignie et al 1962), in Rhodesia (Gelfand and 
Forbes 1963) and in Uganda (Otim 1975) . According to Lai et al (1968) 
it did not appear to be uncommon in Indian insulin-dependent diabetic 
patients. 
51 
IDDM of more than 10 years was very commonly associated whith retino-
pathy in the African and Indian patients reported in this study. 
Comparison with other groups who had their illness for over 10 years 
shows a prevalence of 80 per cent in young Kenyan diabetics (Steel et 
al 1977) , 14% in Nigerian diabetics (Osuntokun 1969) and 22% in Uganda 
(Otim 1975). In Sweden a frequency of 35.7 per cent was found in 
young diabetics who had the disease for 8-15 years and 100% of those 
who had it for more than 16 years (Nilsson et al 1967). 
In young white diabetic patients seen at Joslin Clinic retinopathy was 
rare (2%) if the duration of the disease was less than 10 years (Kahn 
and Bradley 1975) whereas it was common (48%) in young Kenyans also 
falling into this category, (Steel et al 1977). The African and Indian 
patients in this study also did not appear to be particularly prone to 
this complication if IDDM was present for less than 10 years, although 
the frequency (7% and 12,5% respectively) was somewhat higher than the 
Joslin Clinic patients (2%) with a similar duration of disease (Kahn 
and Bradley 1975). 
The rarity of proliferative retinopathy in this study may be due to the 
disease being present for a relatively short duration in the vast major-
ity of the patients (mean 4.3 years). Nevertheless, this form of 
retinopathy appears to be uncommon according to Dorf et al (1976)and 
Nilsson et al (1967), who found prevalence rates of 7% and 2.9% re-
spectively in diabetic patients with retinopathy. Knowles (1971), 
however, estimates that almost 50 per cent eventually develop this 
complication during the course of 30 years of diabetes. 
Diabetic nephropathy is the major cause of death in insulin-dependent 
diabetic patients, (West 1978). It accounts for up to 40 per cent of 
deaths in IDDM (Marks and Krall 1971). Although the prevalence of 
nephropathy varies, its frequency has been found to be up to 30 per 
cent in patients who have had the disease for more than 15 years 
(Bjerkelund 1951). 
Whilst proteinuria is a useful index of diabetic nephropathy, it is 
not very sensitive (West 1978). Thus the rarity of nephropathy in this 
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study may be due to the relatively insensitive method of detecting this 
complication, although the relatively short duration of IDDM in most of 
the patients may also play a part. 
The 6 patients with nephropathy constitute 10% of those who had the 
disease for more than 7 years. Nilsson et al (1967) found a similar 
frequency of proteinuria in their young diabetic patients with duration 
of disease longer than 7 years. 
All 6 patients had retinopathy, which has been found to be invariably 
associated with nephropathy (Bjerkelund 1951). 
In the majority of cases cataracts complicating diabetes mellitus are 
of gradual onset (Oakley et al 1973). Such lesions have been found in 
50 per cent of young diabetic patients after 11 years of disease (Knowles 
et al 1965). In this study, however, only 20% of the patients who had 
IDDM for more than 10 years manifested with this type of cataracts. 
All those with this complication had had the disease for more than a 
decade. Dense subcapsular cataracts which are rare and develop in some 
young patients who have had diabetes for a short time (Oakley et al 
1973) were the more common type of cataracts seen and were only observed 
in the African patients. 
An association between hypertension and diabetes has been found in many 
studies (Christlieb 1973; Jarret and Keen 1975; Vaishnava and Bhasin 
1969). Obesity and diabetic glomerulsclerosis probably account for the 
increased frequency of hypertension in diabetic patients (West 1978). 
In IDDM hypertension is rare at the onset of the disease, with the fre-
quency rising precipitously after 10 years of diabetes to such an extent 
that about 50 per cent of patients have hypertension after thirty years, 
(Christlieb 1973). 
In this study, of the 6 patients who had hypertension only three patients 
had nephropathy as judged by proteinuria. Nevertheless, the other 
patients would probably have shown evidence of nephropathy had a more 
sensitive method to estimate urinary protein been used. All the patients, 
except one, had had IDDM for a long time. Such a finding is in keeping 
with Christlieb's observation (1973). 
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The increased frequency of tuberculosis in diabetic patients was ob-
served by Avicenna as long ago as the 10th century (Root 1940; Root and 
Bloor 1939). Since the incidence of tuberculosis in Africans is very 
high even in the general population, it is not surprising that this in-
fection should manifest itself in diabetic patients more commonly than 
in non-endemic areas. Thus the frequency rate of 6.5% for active pul-
monary tuberculosis is much higher than in Jamacian diabetic patients 
who had a rate of 0.9% (Tulloch 1962) and in a group of American patients 
who had a rate of 2% (Dillon et al 1952). In previous studies rates of 
2.5% (Seftel and Schultz 1961) and 4.5% (Campbell and McNeill 1959) have 
been reported among Africans in South Africa. Deshmukh et al (1966) 
found a prevalence rate of 8.3% among known patients who had routine 
chest radiographs done. 
The insulin requirements in both the African and Indian patients are 
higher than those in White Caucasians from other countries, where the 
average dose is about 1.00 u/kg/day. (Larsson 1977). Although it has 
been suggested than an insulin dose greater than 1 unit per kilogram 
per day may be a sign of over-treatment (Tattersall 1978), very few 
patients manifested with signs of overtreatment which include frank 
hypoglycaemic episodes, wide swings in urine and blood glucose, negative 
evening urine tests with 2% glycosuria next morning, refractive changes, 
and hepatomegaly and oedema (Tattersall 1978). A possible reason for 
the relatively high insulin requirements in these patients is that since 
many of the patients find it difficult to afford a strict diabetic diet, 
the dose of insulin has to be increased to improve metabolic control. 
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SUMMARY 
Insulin dependent diabetes mellitus (IDDM) with onset below 35 years 
of age was studied in 92 African and 41 Indian patients. The mean age 
of onset was lower and the mean duration of disease longer in the 
Indian compared to the African patients. African patients tended to be 
heavier than the Indian patients. A positive family history of diabetes 
mellitus was obtained in over 50% of Indian, but in olny 13% of African 
patients. Onset of IDDM was more common in winter than in summer, 
particularly among Indian patients. The initial presentation in more 
than 90% of the patients was acute, with severe ketoacidosis in 11%. 
Almost 70% of the African and 50% of the Indian patients developed 
ketoacidotic coma on one or more occasions. It was a presenting 
feature in over 50% of the former and 25% of the latter groups. Most 
of the other complications were related to the duration of IDDM. The 
mean daily insulin requirements were high in both population groups. 
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CHAPTER IV (A) 
CLINICAL FEATURES OF NONINSULIN-DEPENDENT 
DIABETES IN YOUNG AFRICANS AND INDIANS 
INTRODUCTION 
Non insulin-dependent diabetes in the young has only relatively recently 
been recognised as a distinct entity (Fajans and Conn 1968; Fajans et 
al 1978; Tattersall and Fajans 1975). It is relatively uncommon com-
pared to the classical NIDDM seen in the middle and old age groups and 
has been reported from England, the United States, Denmark, India and 
Japan (West 1978). Though behaving like NIDDM of middle and old age 
(Fajans et al 1978), the disease has been shown to be associated with 
far less morbidity in some studies (Barbosa et al 1978; Tattersall 1974). 
Reference to NIDDM in the young in South Africa as an entity distinct 
from the J-type or K-type diabetes of the tropics was first made in 1960 
but some of its features were obscured by its inclusion with a type of 
diabetes mellitus considered to be due to hyperadrenalism and growth 
hormone deficiency (Campbell 1960; 1963). 
MATERIAL AND METHODS 
18 Africans and 61 Indians who fulfilled the following criteria were 
selected and studied: 
1. Age at diagnosis under 35 years 
2. Duration of diabetes greater than 12 months 
3. Control of symptoms on diet with or without oral hypoglycaemic therapy 
only 
4. Absence of ketosis without insulin therapy 
All the patients described in this study had the following data recorded: 
1. Age, sex, height, weight and percentage ideal bodyweight, which was 
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calculated by comparing the actual weight to the ideal body weight of 
a medium frame person of the same height and age group (Documenta 
Geigy 1970). 
2. Age at diagnosis 
3. Duration of diabetes 
4. Family history 
5. Mode of presentarion 
In addition a full physical examination was carried out on each patient. 
Peripheral neuropathy was assessed on the basis of the criteria out-
lined in Chapter II. Fundal examination was done after instillation of 
a mydriatic (as described in Chapter II). Nephropathy was assessed by 
measurement of urinary protein and plasma creatinine levels. If 
either of these parameters was abnormal, a GFR using radiolabelled 
Chromium EDTA was done. 
RESULTS 
Results are shown in Table 1 - 3 and Figure 1 - 3 . 
Age at diagnosis and mean duration of NIDDM; Figure 1 
shows the distribution of patients in relation to the various age 
groups at which NIDDM was diagnosed. The mean age at diagnosis in 
the African patients was 29 years (range 17 - 35) and in the Indian 
patients 27.3 years (range 17 - 35 years). The mean duration of the 
disease was 6.8 years (range 2 - 32) in the Indian patients and 4.3 
years (range 2 - 12) in the African patientsi Figure 2. 
Family History: 
A positive history of diabetes in a first degree relative was present 
in almost 80% of the Indian patients, whereas it was less common in 
African patients, being present in only 39% of them. All the affected 
relatives in both groups had diabetes of the non-insulin*-dependent type. 
In almost two thirds of the Indian patients at least one parent had 
NIDDM whilst in 20% of the cases both parents had the disease. A third 
of the propositi had a sibling suffering from the disease. All 17 
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TABLE 1 CLINICAL CHARACTERISTICS OF PATIENTS WITH NIDDM 
Number of patients 
Male : female ratio 
Mean age of diagnosis in years 
Mean duration of disease in 
years 
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African patients had at least one parent suffering from the disease. 
Sex Incidence; 
There was a female preponderance (F:M = 3 : 1) in both racial groups. 
Weight: 
Figure 3 illustrates the distribution of percentage desirable weights 
in the Africans and Indians with NIDDM. The mean percentage desirable 
weights in the 2 groups are 126% (range 82% - 164%) and 116.8% (range 
87% - 152%), but the difference falls short of statistical significance. 
Almost 40% of the African and Indian patients were obese, i.e. body 
weight greater than 20% of ideal body weight. 
Both the African and Indian patients with NIDDM were significantly 
heavier than their corresponding counterparts with IDDM (p < 0.0025 and 
p < 0.0005 respectively). 
Mode of Onset: 
In both groups over 60% of the patients had an insidious onset charac-
terised by non-specific symptoms of tiredness, malaise and nocturia. 
In 11% of the patients the onset was subacute with polydipsia and 
polyuria. A similar proportion of patients presented for the first 
time in pregnancy with the diabetic state persisting for more than a 
year later in all of them. In 9% of patients NIDDM was diagnosed after 
routine examination had shown glycosuria. 
Complications: 
Tables 2-3deprts the frequency of complications in the African and Indian 
patients described in this study. 
Peripheral Neuropathy: 
16 Indian patients (27%) had neuropathy, whereas only 1 African patient 
showed this complication. The mean duration of the disease in all the 
patients with peripheral neuropathy was 10 years (1 - 32 years). 
Only one patient had symptoms of neuropathy, whilst 17% showed absent 
ankle reflexes. Less common signs were impaired vibration sense seen in 
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Figure 3 
THE DISTRIBUTION OF PERCENTAGE DESIRABLE 
WEIGHTS IN ADULTS (over age 2 5 ) WITH NIDDM 
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TABLE 2 
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4 patients and impaired position sense found in 2 patients, whilst 
motor deficit was not present in any of the patients. 
Autonomic Neuropathy: 
None of the patients had evidence of autonomic neuropathy. 
Retinopathy: 
Background retinopathy was present in 3 African patients (17%)and 16 
Indian patients (27%). The mean duration of known disease in the 2 
groups was 2 years (range 2 - 4 years) and 10.5 years (range 2-32 
yrs) respectively. Proliferative retinopathy was present in 1 patient only. 
Nephropathy: 
Nephropathy was present in 5 Indian and 1 African patient. All the 
patients had albuminuria. The mean duration of NIDDM in these patients 
was 10.6 years (range 5-19 yrs). In 4 patients the duration of 
disease was less than 7 years. The mean glomerular filration, which 
could be done on 3 of the patients, was 51 ml/minute (range 21 - 76). 
Large Vessel Disease: 
Only 3 patients had evidence of macrovascular disease, 2 showing peri-
pheral vascular disease and 1 ischaemic heart disease. 
Hypertension: 
Hypertension was rare, being present in only one patient. 
DISCUSSION 
As NIDDM in the young has been known for a relatively short time, it is 
hardly surprising that little information is available on the epidemio-
logy of this entity, in contrast to the extensive information on preva-
lence and incidence rates of NIDDM in the adult (West 1978). A crude 
estimate of the actual prevalence rates of NIDDM in the young may be 
obtained by analysis of studies which give information on the percentage 
of diabetics who are not on insulin (West 1978). In the National Health 
Survey of 1964 - 1965 almost 27% of diabetic patients under 25 years of 
age were not on insulin (Bauer 1967) whilst in a survey of 2 816 school 
children with the disease in Michigan, 15.5% were noninsulin-dependent 
(Gorwitz et al 1976). According to the data from the National Centre 
for Health Statistics only a maximum of 34% of diabetic patients under 
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the age of 39 were on insulin (Sayetta and Murphy 1979). 
In the series of 207 Indian diabetic patients documented by Campbell 
(1960), 16% fell into the category now known as NIDDM in the young. 
In this study NIDDM in the young has been found to be rare in Africans, 
accounting for only 1.7% of the total diabetic population, but much 
more common in Indians accounting for 11% of all diabetic patients. 
Thus if the overall prevalence of diabetes in Africans and Indians is 
taken as 0.7% and 1.8% respectively (West 1978), then the prevalence 
rate for NIDDM in the young is 0.01% in Africans and 0.2% in Indians. 
In a survey done in Erfurt, East Germany, the prevalence rate for the 
disease was found to be .15% (Panzram and Adolph 1981). 
Since NIDDM in the young usually presents insidiously, just as in 
adults, the age of diagnosis does not necessarily coincide with the 
onset of the disease. Hyperglycaemia may be present for a long time 
prior to diagnosis. The age of presentation appears to be earlier in 
Indians, as 50% of the African patients presented with the disease in 
the 4th decade whereas a similar proportion of Indian patients did so 
in the 3rd decade. An attempt to compare the age of diagnosis of the 
patients in this study with those elsewhere is hampered by the fact 
that different workers have chosen their own arbitary age cut-off level 
for categorising diabetes in the young. Thus 14 - 20 years (West 1979), 
25 years (Fajans et al 1976), 29 years ( Christau et al 1977), 31 
years (Deckert et al 1978) and 40 years (West 1978; Seltzer et al 
1967) have all been chosen as age cut-off levels for diabetes in the 
young. Nevertheless the mean age of onset of NIDDM in Africans (29 
years) and Indians (27 years) is well within the 35-year cut off level 
selected for this study. 
Since the first detailed description of NIDDM in the young (Fajans and 
Conn 1968) several workers have observed a striking familial occurrence 
of this entity (Fajans et al 1976). Tattersall (1974) described in 
detail 3 families with 69 offsprings and proposed that NIDDM in this 
group of patients was inherited in an autosomal dominant fashion. 
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Although a positive family history of diabetes in the African with 
NIDDM was less common than in the Indian patients, it was still much 
more common when compared to African insulin-dependent diabetic 
patients. NIDDM in Indians also was much more often associated with » 
a family history of diabetes than IDDM. 
In a group of 26 young patients with NIDDM Tattersall and Fajans 
(1975) found diabetes in at least one parent in 85 per cent of the 
propositi. In addition, 53% of the siblings were found to be diabetic. 
Studies on 58 such patients by Panzram and Adolph (1981) showed the 
presence of diabetes in at least one parent in 74% of the propositi. 
Although diabetes in either parent or in siblings appears to be less fre-
quent in the Indian or African patients in this study, the frequency 
may be higher if all the family members are subjected to a glucose 
tolerance test, as had been done by Tattersall and Fagans (1975) and 
Panzram and Adolph (1981). In this study, data on family history was 
obtained by questionnaire alone and as NIDDM can often be asympto-
matic, cases of undiagnosed IDDM in family members were not accounted 
for by this method. Thus it is quite possible that NIDDM in the 
young Indian particularly is associated with an autosomal mode of 
inheritance. Vague et al (1981) postulate that heredity is compatible 
with autosomal dominance not only in typical NIDDM of the young (MODY) 
but in NIDDM presenting at any age irrespective of the presence or 
absence of obesity. 
NIDDM in middle age (classical maturity onset diabetes) is associated 
with female dominance of varying degrees (West 1978). The W.H.O. 
(1964) found a mean male : female ratio of 1 : 1.5. In some communities 
however, no difference of a male predominance has been found (West 1978). 
Among Indian diabetics a slightly higher male predominance was observed 
(West 1978). In Uganda also the rate among males is higher (Ajgaonkar 
1970). 
In contrast to the extensive data on maturity onset type diabetes, little 
information is available on the sex differences in NIDDM in the young. 
Spiegelman and Marks (1946) found a slightly higher rate of diabetes 
among young women than young men in Massachesettes in U.S.A. In the 
U.S.S.R. the rate was four times as high in females between 30 - 40 years 
66 
of age as in males of the same age group, (West 1978). 
In a series of 26 young non-insulin-dependent diabetics reported by 
Tattersall et al (1975), only 34% were females. In this study, however, 
the disease appeared to be much more common in females. 
NIDDM in the young shows a wide variation in the weights of individual 
patients (West 1979). In the 78 patients with the disease studied by 
Fajans et al (1976) only 18 (23 per cent) were found to be obese, i.e. 
body weight greater than 20 per cent of ideal body weight. However, 
Vague et al (1981), found obesity in 50% of their patients. In this 
study also obesity was common in both African and Indian patients with 
NIDDM. Cosnett (1959) and Campbell (1960, 1963) also commented on the 
frequency of obesity in the young Indian diabetic patients they had 
studied. 
It is possible that a diet leading to obesity is also an important 
environmental factor in the aetiology of NIDDM in the young, as has 
been suggested for the typical maturity onset type diabetes of middle 
and old age (Fajans et al 1978). In this regard studies have been 
done showing that small increases in weight can exacerbate glucose 
intolerance and precipitate fasting hyperglycaemia (Tattersall and 
Fajans 1975; Radder and Terpstra 1975). Hence it is likely that 
obesity together with genetic factors play an important role in the 
pathogenesis of NIDDM in many of the young Africans and Indians re-
ported in this study. 
Although NIDDM in the middle age may present with symptoms, the pre-
sentation is insidious and unlike the abrupt onset characteristic of 
the classical juvenile onset type diabetes mellitus (IDDM) (Tattersall 
and Fajans 1975). Such an insidious onset is also true of NIDDM in 
the young» (Tattersall 1974) . Thus it is hardly surprising that the 
vast majority of African and Indian patients also presented in such a 
fashion. 
Of the 9 young patients with NIDDM described by Johansen (1973), 3 
patients presented with mild symptoms, 5 were asymptomatic (NIDDM 
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being discovered on routine urine examination and 1 patient presented 
in pregnancy. It is difficult to compare the presentation in these 
patients to Fajaris group of 78 patients (Fajans et al 1976) because 
many of his patients were discovered after glucose tolerance tests had 
been done in the family members of the index cases. 
Tattersall (1974) and Barbosa et al (1978) have commented on the rarity 
of vascular complications in their young patients with NIDDM. Others, 
however, have found that such complications are by no means uncommon 
(Fajans et al 1978; Steel et al 1976) and that the frequency may be 
the same as in NIDDM presenting in the middle age or the elderly 
(Fajans et al 1978). In Fajans'study, over 50% of the young non-
insulin dependent diabetics who had the disease for more than 15 years 
had evidence of microvascular or macrovascular disease, thus showing 
that NIDDM in the young is not necessarily a benign disease (Fajians et all978). 
As stated in Chapter III, the prevalence of diabetic neuropathy based 
on clinical criteria has varied from 4 per cent to 40 per cent owing 
to a lack of uniformity in the definition of neuropathy and in methods 
of investigation. 
Although in 3 of the patients with peripheral neuropathy NIDDM had been 
diagnosed less than 2 years previously, it is possible that the meta-
bolic derangement had been present for a much longer time. Hence the 
difference between the duration of the disease in the young insulin 
dependent and the non-insulin—dependent diabetics with peripheral 
neuropathy becomes all the more significant, since the mean duration 
in the former (4.5 years) is less than half of that in the latter. 
Based on simple screening tests as outlined in Chapter II, none of the 
patients showed evidence of autonomic neuropathy, which is still con-
sidered relatively uncommon (Ward 1978). Nevertheless, many patients, 
although asymptomatic have been found to show evidence of autonomic 
dysfunction using more sensitive methods (Thandroyen et al 1980). 
Retinopathy was present in almost 60% of Indian patients who had NIDDM 
for more than 10 years. Fajans et al (1978) found a prevalence of 18 
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per cent in patients who had the disease for more than 15 years. In 
Tattersall's series (1974) however, only 2 out of 14 patients with a 
mean duration of NIDDM of 24 years had evidence of retinopathy. Thus 
retinopathy appears to be particularly common among young Indians with 
NIDDM. Only one patient, an Indian who had known disease for 12 years, 
showed evidence of proliferative retinopathy. This complication has 
also been found to be rare in other studies (Dorf et al 1976; Nilsson 
et al 1967). 
Nephropathy is a less common cause of death in late onset diabetes than 
in childhood diabetes (Marks and Krall 1971). Data on the frequency of 
this complication in NIDDM in the young suggest that it is very rare 
(Tattersall 1974). In the series of 69 patients reported by Fajans et 
al (1978) only one had nephropathy. The duration of disease 
in him was more than 15 years. None of Tattersall's patients (1974) 
had nephropathy as gauged by the presence of proteinuria, despite a 
mean duration of disease of 24 years. 
It would appear that nephropathy tends to occur earlier in young Indian 
patients with NIDDM, than in those with IDDM, since none of the 16 
insulin—dependent patients who had the disease for 5 to 10 years 
developed this complication, compared to 19% of the non-insulin depen-
dent diabetic patients with a similar range of duration of illness. 
It is unlikely that poorer metabolic control in patients with NIDDM 
could account for this difference, because in general they show lower 
glycosylated haemoglobin values than patients with IDDM (Chapter VIII). 
Thus the development of nephropathy may be independent of metabolic 
control in such patients and may be related to other causes, e.g., 
genetic factors. However, the longer interval between onset of meta-
bolic abnormality and diagnosis of NIDDM could also account for the 
higher frequency of this complication in such patients. In older non-
insulin-dependent diabetic patients also nephropathy has been found to 
develop earlier when compared to patients with IDDM (Martin and Stocks 1968) . 
Macrovascular disease appeared to be uncommon in the African and Indian 
diabetics with NIDDM reported in this study as only 2 patients had 
peripheral vascular disease and 1 had ischaemic heart disease. In the 
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series reported by Fajans et al (1978), 13 per cent of their young 
patients with NIDDM had peripheral vascular disease,with a similar pro-
portion developing myocardial infarction. However, almost 50 per cent 
of their patients had had the disease for more than 15 years and most 
of the complications were present in this group. On the other hand in 
this study there were only 6 patients with duration of disease more than 
15 years and this could explain the rarity of ischaemic heart disease 
and peripheral vascular disease. Nevertheless, large vessel disease 
has been found in one study to be uncommon in young non-insulin-dependent 
diabetic patients (Tattersall 1974). 
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SUMMARY 
Non insulin dependent diabetes mellitus (NIDDM) with onset below 35 
years of age was studied in 60 Indian and 18 African patients. There 
was a female preponderance in both groups. The mean age at diagnosis 
was 27.3 years in the Indian and 29 years in the African group. The 
former group had a longer mean duration of NIDDM than the latter (6.8 
years and 4.3 years respectively). A positive family history of 
diabetes mellitus was obtained from over 80% of the Indian and less 
than 40% of the African patients. Obesity was common in both racial 
groups, almost 40% of patients having a percentage ideal body weight 
of more than 120%. The mode of presentation was symptomatic in most 
patients, although the onset was often insidious. Microvascular com-
plications were detected in almost a third of the patients, but macro-
vascular complications were rare. 
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CHAPTER IV (B) 
NON INSULIN - DEPENDENT DIABETES PROGRESSING TO 
INSULIN DEPENDENCE 
INTRODUCTION 
In the course of our study on diabetic patients with age of onset under 
35 years, we found a considerable number who could not be categorised 
as either insulin dependent or non-insulin dependent according to the 
criteria used in this study. These were patients who to all intents 
and purposes presented initially like the typical NIDDM, i.e. with an 
insidious onset and were responsive to diet with or without oral hypo-
glycaemic drugs for a number of years (mean 9.8 years) without develop-
ing ketosis during that period. However, because of development of 
symptoms during later years they had to be treated with insulin. These 
patients were thus insulin- dependent but unlike the typical ketosis 
prone IDDM described in Chapter III, became so much later. 
It is quite likely that the major difference between the typical NIDDM 
and this entity (NIDDM progressing to IDDM) is one of duration, the 
latter representing progression of the disease in a way similar to the 
typical NIDDM of older age group decompensating to insulin-dependent diabetes 
with time. However, since there may be other factors as well, they 
will be discussed separately. 
MATERIALS AND METHODS 
19 Indian patients and 5 African patients fell into this group accord-
ing to the following criteria: 
1. Age at presentation of diabetes under 35 years. 
2. Control of symptoms by diet with or without oral hypoglycaemic 
therapy for at least 2 years after diagnosis (Fajans et al 1976). 
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3. Absence of ketosis without insulin therapy during the entire 
period of dietary therapy with or without oral hypoglycaemic drugs. 
4. Eventual dependence on insulin because of symptoms. 
The following data were recorded in all the patients:-
1. Sex, age, height, weight and percentage of ideal body weight, calcu-
lated as shown earlier in the chapter. 
2. Age at diagnosis. 
3. Duration of diabetes. 
4. Interval between diagnosis of diabetes and commencement of insulin 
therapy. 
5. Episodes of ketosis (after commencement of insulin therapy). 
6. Family history of diabetes. 
7. Mode of presentation. 
In addition a full physical examination was carried out on each patient. 
Peripheral and autonomic neuropathy were assessed according to the 
criteria outlined in Chapter II. Fundal examination was done after 
instillation of a mydriatic (as described in Chapter II). Nephropathy 
was assessed on the basis of proteinuria and elevated serum creatine 
levels. 
RESULTS 
Results are shown in Figures 4 - 7 and Tables 4-5. A comparison of 
the various clinical parameters and complications between patients 
belonging to this group and those who have always been non-insulin 
dependent is shown in Table 4. 
The mean age of onset in African and Indian patients was 27 years 
(range 14 - 34). The disease tended to occur earlier in the Indian 
(mean 25 years, range 14 - 35 years) than African patients (mean 29 
years, range 22 - 34). The mean age of onset of the disease in these 
patients was similar to that of patients who had always been non-
insulin-dependent (mean 26 years). However, as can be seen in Figure 
5 the mean duration of diabetes in the former (mean 14 years, range 
5-26 years) was much longer than in the latter (mean 6.2 years), 
range 1-32 years). The mean interval between diagnosis and commence-
ment of insulin therapy was9.8 years (range 4-25 years). Figure 6. 
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TABLE 4 COMPARISON OF THE CLINICAL CHARACTERISITCS AND PREVALENCE 
OF COMPLICATIONS IN PATIENTS WHO HAVE ALWAYS BEEN NON-
INSULIN DEPENDENT (NIDDM) AND THOSE WHO WERE INITIALLY 
NON-INSULIN DEPENDENT BUT LATER REQUIRED INSULIN. 
Number of patients 
Male : female ratio 
Mean age of diagnosis 
in years 
Mean duration of 


























































































































THE DISTRIBUTION OF PATIENTS IN RELATION 
TO THE AGE OF PRESENTATION IN THOSE 
PROGRESSING FROM NIDDM TO INSULIN 
DEPENDENCE 
All mean = 26yrs. 
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Figure 5 75 
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COMPARISON OF THE DURATION OF DIABETES IN PATIENTS 
WHO HAVE ALWAYS BEEN NON INSULIN-DEPENDENT (NIDDM) 
AND THOSE REQUIRING INSULIN LATER 
I I NIDDM : mean= 6.2 years 
0 - 5 6-10 11-20 >21 
Duration in years 
Figure 6 77 
The Distribution of 
the Intervals between 
Presentation (with N.I.D.D.M.) 
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In 71% of the patients there was at least one first degree relative 
suffering from diabetes mellitus, which was of NIDDM type in all of 
them. All patients with a positive family history had at least one 
parent suffering from NIDDM. Whilst in over 50% of the patients both 
parents were suffering from the disease, the mother was affected in 
everyone of them. 
Obesity was common, as can be seen from the distribution of percentage 
desirable weights depicted in Figure 6. Over 40% of the patients were 
found to have a weight greater than 120% of ideal body weight. Even in 
patients who had always been non insulin-dependent a similar proportion 
had a body weight greater than 20% of IBW, although they had a lower 
mean percentage ideal body weight (116.8% vs 125%). 
Complications 
Table 5 shows details of the complications found in the patients belong-
ing to this group. Comparison of the frequencies of complications 
between these patients and those who have always been non insulin-
dependent (NIDDM) shows that they are much more common in the former 
group, Table 4. 
Peripheral Neuropathy 
Although an absent ankle jerk was the commonest abnormality of peri-
pheral nerve function (present in 56% of patients), impaired vibration 
sense was seen in nearly 20% of patients. 
Retinopathy 
Of the 16 patients with retinopathy, 12 had the background type and 4 
the proliferative type. Only 2 of the 11 patients who had diabetes 
mellitus for more than 15 years did not show evidence of retinopathy. 
In the group with proliferative retinopathy the disease was present 
for more than 20 years in 2 patients (50%). 
Nephropathy 
Nephropathy was common, being present in 6 patients (24%), all of whom 
had the disease for over 10 years. The mean duration of disease was 16 
years (range 11 - 26 years). The mean GFR in the patients was 48 ml per 
minute, (range 28 - 75 ml). 
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TABLE 5 MEAN DURATION OF DISEASE IN PATIENTS (INITIALLY NIDDM, 
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and the mean serum creatinine concentration 281 mE/L (range 88 - 955 
mE/L). In 2 patients the creatinine concentration was normal, despite 
the presence of persistent albuminuria. All the patients with nephro-
pathy also had retinopathy. 
Hypertension 
Hypertension was present in 5 patients, being associated with nephropathy 
in 3 of them. The mean duration of disease was 17 years (11 - 21 years). 
Macrovascular Disease 
According to the criteria used in this study, ischaemic heart disease 
and peripheral vascular disease were not common. 
DTSCUSSION 
Fajans et al (1976) described a group of young diabetic patients who 
were initially controlled on diet with or without sulphonylureas but 
who later became insulin-dependent. In their proposed classification 
this group is described as being more akin to non-insulin dependent 
diabetes mellitus as regards inheritance, provided that the patients 
become insulin-dependent more than 2 years after diagnosis. 
If the 24 patients described in this study are included with the 
patients who have always been non-insulin dependent, then they con-
stitute about 28 per cent of all the patients initially presenting with 
NIDDM. In the series described by Fajans et al (1976) 20 per cent of 
the patients who presented with NIDDM progressed to insulin dependence 
with time. 
There was no significant difference between the ages of onset in patients 
not requiring insulin and those who eventually became insulin dependent. 
In Fajan's (1976) series of 9 patients who were initially diagnosed as 
NIDDM but later became insulin dependent at least 2 years later, the 
mean age of onset of the disease was 21 years. 
whilst the mean interval between discovery of diabetes and commencement 
of insulin therapy was 10 years in the patients described in this study 
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a much shorter interval (mean 6 years) was observed by Fajans et al 
(1976). Thus it appears that the NIDDM that progresses to IDDM is of 
a milder type in African and Indian patients than in the group described 
by Fajans. 
The high frequency of a positive family history of diabetes, similar to 
that seen in the African and Indian patients who have always been 
non-insulin dependent, corroborates the observations of Fajans et al 
(1976) who concluded that patients initially diagnosed as NIDDM and 
later requiring insulin usually show the pattern of inheritance seen 
in classical NIDDM of the young. Another striking finding was the presence 
of a much higher frequency of diabetes in either parent (100%) or 
in both parents (55%), compared to the patients who have always remained 
non-insulin dependent. 
Vascular as well as neurological complications were frequently seen in 
this group of patients and were much more common than in patients with 
either NIDDM or IDDM. The longer duration of diabetes in many of these 
patients as compared to the other groups probably accounts for this 
increase. Nevertheless, the less likely possibility that this group 
is particularly prone to complications irrespective of the duration of 
disease cannot be ignored. 
Retinopathy was present in 68 per cent of the patients. Whilst 82% of 
the patients who had the disease for more than 15 years showed evidence 
of retinopathy, a similar percentage of the non-insulin dependent 
diabetics reported by Fajans et al (1978) did not have this complication. 
Comparison with Fajans et al's 11 patients who later became insulin 
dependent is not possible because the frequency of retinopathy in all 
the patients was documented and not shown separately. 
Nephropathy appeared to be common in this group of patients, presumably 
because of the long duration of disease in most of them. In contrast 
only one out of 69 patients reported by Fajans et al (1978) had this 
complication, despite a duration of NIDDM of over 15 years in almost 
50 per cent of them. 
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The rarity of ischaemic heart disease in this group of patients is 
rather surprising in view of the long history of diabetes in many of 
them. In the series reported by Fajans et al (1978) there was an 
equal incidence of ischaemic heart disease and retinopathy in patients 
who had the disease for more than 15 years. 
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SUMMARY 
Nineteen Indian and five African patients who were intially non-
insulin dependent but later required insulin were studied. They con-
stitute 28% of all the patients initially presenting with NIDDM. The 
mean age of presentation was lower and the mean duration of disease 
much longer in the Indian compared to the African patients. A positive 
family history of diabetes was obtained in over 70% of patients. The 
mean interval between presentation of NIDDM and commencement of insulin 
therapy was 10 years. Obesity was common, over 40% of patients having 
a percentage ideal body weight of over 120%. Microvascular compli-
cations were common and appeared to be related to duration of disease. 
Macrovascular complications were infrequent. 
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CHAPTER V 
BETA CELL FUNCTION IN 
INSULIN—DEPENDENT DIABETIC PATIENTS 
INTRODUCTION 
Studies of endogenous insulin secretion based on C-peptide measurements 
have provided valuable information on residual pancreatic beta cell 
function in insulin-dependent diabetic patients (Block et al 1972; 
Faber and Binder 1977a; Grajwer et al 1971; Heding and Rasmussen 
1975). Almost 100 per cent of patients with duration of diabetes under 
two years have been shown to have some residual beta cell function and 
with longer duration the prevalence decreases progressively, reaching 
a level of about 15 per cent after 15 years of disease (Madsbad et al 
1978). Greatly reduced beta cell function has been shown to be asso-
ciated with poor control of diabetes (Faber and Binder 197» and with 
elevated plasma ketone bodies (Madsbad et al 1977). Even the prevalence 
of retinopathy appears to be lower in long-standing diabetic patients 
with persisting beta cell function (Eff et al 1978). 
Virtually all the published data on C-peptide measurements have been 
confined to White Caucasian populations and there have certainly been 
no reports of residual beta cell function in Indian and African diabetic 
patients in South Africa. The present study was undertaken to evaluate 
beta cell secretory reserve following glucagon or glucose provocation 
in insulin dependent African and Indian diabetic patients. 
MATERIALS AND METHODS 
The study was carried out in 2 parts. 
In the first part the C-peptide response to glucagon was assessed in 
35 insulin-dependent diabetic patients, all of whom were part of the 
group described in Chapter III, and 22 normal adults. 
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The healthy adults who served as controls comprised 11 Africans and 
11 Indians. The male : female ratio in each group was equal. The 
mean age and weight of the healthy controls were 23 years and 61 Kg 
respectively. None of them had diabetes mellitus or a family history 
of the disease. 
Table 1 lists the clinical features of the diabetic patients studied. 
Patients and healthy subjects were studied in the mornings after an 
overnight fast (the last meal having been taken at 1830 hrs the 
previous day with a snack at 20H00). No insulin was given on the 
morning of the test day and only soluble insulin was used on the 
evening before the test to ensure that there would be no residual 
depot action of long acting insulin. 
The patients and controls remained seated throughout the procedure and 
were not permitted to eat, chew or smoke. Informed consent was 
obtained from all the subjects. Blood samples were collected through 
indwelling cannulae inserted under local anaesthesia 3€ minutes prior 
to the test. In initial studies free flowing venous blood was collected 
5 minutes before and at 2, 4, 6, 8, 10, 15 and 20 minutes after an 
intravenous injection of glucagon (Img) in 13 African and 5 Indian 
patients, and 10 normal subjects (6 Africans and 4 Indians). 
As a significant correlation was found between the maximal rise in the 
C-peptide level and the level observed at 6 minutes (Figure 1), in 
subsequent studies blood for C-peptide assays was taken before, and 
6 minutes after glucagon injection in a further 17 patients and 12 
normal subjects. 
Plasma C-peptide was measured by radioimmunoassay (Byk-Mallinckrodt 
kit). The effective detection limit of C-peptide in this assay was 
0.055 nmoles/litre and the cross-reaction with human pro-insulin 
about 10%. 
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TABLE 1 CLINICAL CHARACTERISTICS OF THE DIABETIC PATIENTS UNDERGOING 
THE GLUCAGON TEST 
Number of patients 
Male : female ratio 
Mean weight 
Mean age in years 
Mean duration in years 
Mean insulin dose in 
Iu/Kg/day - s.E. 
Total 
35 
10 : 25 
23 
4 
1.49 +_ 0.12 
Africans 
25 




1.57 +_ 0.15 
Indians 
10 




1.32 +_ 0.21 
TABLE 2 CLINICAL CHARACTERISTICS OF THE PATIENTS WITH IDDM UNDERGOING 
A GLUCOSE TOLERANCE TEST 
Number of patients 
Mean w ght (Kg) 
Male : female ratio 
Mean age in years (range) 
Mean duration in years 




13 : 14 
24 (12-38) 
3.3 (^9) 




2 : 1 
25 (12.37) 
7.2 (T3Z-18) 
1.36 +_ 0.16 
Total 
39 
7 : 6 
24.3 
4.5 
1.35 +_ 0.11 
TABLE 3 CLINICAL CHARACTERISTICS OF PATIENTS PRESENTING WITH NIDDM 
AND LATER PROGRESSING TO INSULIN DEPENDENCE 
Number of patients (all Indians) 
Mean weight in Kg 
Male : female ratio 
Mean age in years (range) 
Mean duration in years (range) 
Mean duration of insulin therapy in 
years (range) 
Mean insulin dose (Iu/Kg) ~ S.E. 
6 
62.7 (45-68) 




1.35 + 0.08 
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Figure 1 
CORRELATION BETWEEN THE 6 MINUTE C-PEPTIDE AND THE 
MAXIMAL C-PEPTIDE LEVELS AFTER GLUCAGON STIMULATION 























6 minute C-peptide concn. nmol 
1.5 
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In the second part of the study the C-peptide response to a glucose 
load was measured in 27 African and 12 Indian patients who had always 
been insulin-dependent and in 6 patients who had initially been non-
insulin-dependent but later became insulin-dependent. The 39 patients 
formed part of the patients described in Chapter III whilst the latter 
group was part of the subgroup described in Chapter IV. In addition 
18 healthy adults (9 Africans and 9 Indians) served as a control group. 
The mean age and weight of the healthy subjects who served as controls 
were 23 years and 58 Kg respectively. There was no significant dif-
ference in the male : female ratio in both African and Indian control 
groups. 
Table II lists the clinical characteristics of the subjects studied. 
Patients and healthy subjects were studied in the morning after an 
overnight fast. They remained seated throughout the procedure and 
were not permitted to eat, chew or smoke. Informed consent was 
obtained from all the subjects. Indwelling cannulae were introduced 
into antecubital veins under local anaesthesia and kept patent with 
slow infusions of 0.9% NaCl. After a rest period of 30 minutes blood 
samples for basal glucose and C-peptide levels were collected. 
A drink of 100 gm glucose dissolved in 300 ml water was then given 
slowly. Blood for glucose and C-peptide was taken at 15, 30, 45, 60, 
90, 120 and 150 minutes after the first sip of glucose. 
Plasma C-peptide was measured by radioimmunoassay (Byk-Mallinkrodt 
kit). The method used was a modification of that used for the samples 
taken during the glucagon test. The reason for the change was that 
the kits using the first method had become unavailable and those with 
the modification were introduced. The latter was less sensitive, the 
effective detection limit being 0.1 mmol/L. 
In all the patients and controls plasma glucose concentrations were 
measured by means of an autoanalysert using a ferricyanide method. 
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RESULTS 
1. C-Peptide Response to Glucagon: The basal and 6 minute post-
glucagon C-peptide results in the patients and controls are depicted in 
Figure 2. The mean fasting C-peptide level in the control group 
is 0.49 +_ 0.20 nmoles/L and the mean value 6 minutes after glucagon is 
1.24 _+ 0.48 nmoles/L. This is a more than two-fold increase and is 
highly significant (p < 0.001). The mean basal and 6 minute C-peptide 
concentrations in African controls (0.42 +_ 0.05 nmol/L and 1.17 +_ 0.14 
nmol/L respectively) were lower than those in Indian controls (0.61 +_ 
0.06 nmol/L and 1.40 +̂  0.12 nmol/L respectively), but the differences 
were not significant. 
The mean basal C-peptide level in the patients is 0.32 +_ 0.23 nmoles/L. 
The mean 6 minute post glucagon value is 0.56 +_ 0.47 nmoles/L and rep-
resents a 75% increase over the basal level. In 7 patients the rise 
in the C-peptide level after glucagon injection is not significant, if a 
rise of 16,2% or greater is considered significant, (Eff et al 1978; 
Faber and Binder 1977a). On the other hand 4 patients have markedly 
elevated basal and post glucagon C-peptide levels. Compared to the 
controls, the diabetic patients show significantly lower basal C-peptide 
levels (p < 0.01) and in addition a significantly less relative increase 
after glucagon (p < 0.001). 
The African patients demonstrate significantly lower basal C-peptide 
level (mean 0.30 +_ 0.22 nmoles/L) than the Indian patients (0.43 +_ 0.27 
nmoles/L) (p < 0.001). The corresponding post-glucagon values of 6 
minutes are also lower in Africans (0.43 +_ 0.25 nmoles/L) than Indians 
(0.73 +_ 0.53 nmoles/L, p < 0.0001). 
Figure 3 illustrates the basal and maximal post-glucagon C-peptide 
levels in the diabetic patients and the controls who had C-peptide 
assays done at -5, 2, 4, 6, 8, 10, 15 and 20 mintues after glucagon 
injection. It is evident that the mean basal and the mean maximal 
values in the diabetics are significantly lower than in the controls 
(p < 0.04). The 6 minute values are significantly correlated with the 
maximal levels (r = 0.80; p < .001), Figure 1. 
Figure 2. 
C-PEPTIDE CONCENTRATIONS BEFORE AND 6 MINUTES 
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FASTING C-PEPTIDE CONCENTRATIONS AND THE MAXIMAL C-PEPTIDE 
LEVELS AFTER GLUCAGON STIMULATION IN DIABETICS AND CONTROLS. 
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The mean fasting blood glucose level is 17.8 nmoles/L, and shows no 
correlation with either the basal or maximal post-glucagon C-peptide 
level, Figure 4. 
2. C-Peptide Response during a GTT: The basal C-peptide levels and 
the levels during a GTT in the patients and controls are depicted in 
Figures 5 and 6. 
The mean fasting C-peptide level in the control group is 0.22 +_ 0.04 nmol 
The mean maximal value is 2.15 _+ 0.31 nmol/L, representing almost a 
10-fold increase, which is highly significant (p < 0.0005), Figure 7. 
The maximal C-peptide level in Africans (1.45 +_ 0.20 nmol/L) is signifi-
cantly lower than the mean maximal level in Indians (2.59 +_ 0.49 nmol/L), 
p < 0.05, Figure 8. 
The mean basal C-peptide level in the patients is 0.26 +_ 0.04 nmol/L. 
The mean maximal value during the GTT is 0.53 _+ 0.08 nmol/L and repre-
sents a 2-fold rise over the basal level, Figure 7. Compared to the 
controls the diabetic patients show significantly lower maximal C-peptide 
levels (p < 0.0005). The peak C-peptide response occur later in the 
diabetic patients (mean 137 minutes after glucose ingestion) than in 
the controls (mean 54 minutes), p < 0.0005, Figure 6. 
Although the mean basal and maximal C-peptide levels are lower in the 
African patients compared to the Indian patients, the difference is 
not significant, Figure 7. Similarly there is no significant difference 
in the time taken for the maximal C-peptide to manifest between the 
2 groups, Figure 8. 
In 10 patients (5 African and 5 Indian) C-peptide levels are undetect-
able in the serum and remained so during the GTT. They include 3 
patients with IDDM of recent onset (less than 6 months). The remainder 
had a mean duration of diabetes of 15 years. 
The Indian patients who had always been insulin-dependent had mean 
basal C-peptide levels of 0.27 + 0.07 nmol/L and mean maximal values 
of 0.51 + 0.15 nmol/L, whereas Indian patients who were initially non-
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Figure 4. 
THE RELATIONSHIP BETWEEN FASTING PLASMA C-PEPTIDE LEVELS AND FASTING 
PLASMA GLUCOSE AND BETWEEN MAXIMAL PLASMA C-PEPTIDE LEVELS AND 
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insulin-dependent but later needed insulin show mean basal levels of 
0.34 +_ 0.14 nmol/L and mean maximal levels of 0.53 +_ 0.21 nmol/L. 
There is no significant difference between the 2 groups. 
Fasting plasma glucose concentrations show no significant correlation 
with the basal or maximal C-peptide levels, Figure 4. Similarly no 
significant correlation is seen between the daily insulin requirements 
and the basal or maximal C-peptide concentrations, Figure 9. 
Duration of insulin therapy also shows no significant correlation with 
the basal or maximal C-peptide levels, Figure 10. However, a signifi-
cant correlation is seen between the ages of onset of IDDM and the 
fasting C-peptide levels, Figure 11. 
DISCUSSION 
The determination of C-peptide levels in response to a variety of 
stimuli has been documented in many studies. The stimuli used included 
glucose (Block et al 1972; Block et al 1973; Heding and Rasmussen 
1975; Ikeda et al 1975; Kuzuya et al 1976; Reynolds et al 1977), 
arginine (Reynolds et al 1977) and glucagon (Faber and Binder 1977a; 
Henriksen et al 1977; Ludvigsson and Heding 1977). In the present 
study residual beta cell function was demonstrated in most insulin-
dependent diabetics both by the detection of basal C-peptide levels, as 
well as by the augmentation of C-peptide secretion in response to glucose 
or glucagon. 
C-peptide levels were undetectable in only 12 per cent of the patients. 
In other large studies, however, over 50% of insulin-dependent diabetic 
patients have been found to show no detectable C-peptide levels (Binder 
and Faber 1978; Hendriksen et al 1977). A possible reason for this 
discrepancy is that the duration of diabetes of most of the patients 
reported in the other studies was much longer than that of the patients 
described here. Beischer et al (1976) and Ludvigsson and Heding (1977) 
have also found a much lower frequency of undetectable C-peptide con-
centrations if diabetes was present for a shorter duration. 
Figure 9. 
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THE RELATIONSHIP BETWEEN INSULIN REQUIREMENTS AND BASAL 
AND MAXIMAL PLASMA C-PEPTIDE LEVELS IN INSULIN DEPENDENT 
DIABETIC PATIENTS 
A Maximal C- peptide -glucagon test r=0.22 PN.S. 
a Maximal C-peptide-GTT r= -0 .25 PN.S. 
• Fasting C-peptide- r = - 0 . 0 9 PN.S. 
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THE RELATIONSHIP BETWEEN DURATION OF INSULIN THERAPY AND FASTING AND 

















• Fasting C- peptide r= 0.06 PN.S. 
o Maximal C-peptide-GTT r= 0.104 PN.S. 







Duration of insulin therapy in years 
101 
Figure 1 1 . 
THE CORRELATION BETWEEN AGE OF ONSET OF IDDM AND FASTING PLASMA 
C-PEPTIDE CONCENTRATIONS 
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Patients with undectable basal C-peptide levels very seldom demonstrate 
a significant response to stimuli (Hendriksen et al 1977). Thus it is 
not surprising that only one of the 11 patients with no detectable 
basal plasma C-peptide showed a significant response during a GTT. 
Although the mean C-peptide level was significantly lower in the diabetic 
patients than the controls, a significant response to glucose or glucagon 
was seen in most of the patients. However, 20% of the patients under-
going the glucagon stimulation test failed to show a significant response 
to glucagon. In Hendriksen's Series (Hendriksen et al 1977), 15% of 
the patients who had detectable basal C-peptide levels did not show a 
significant response to glucagon. Of the patients who underwent a 
glucose tolerance test less than 10 per cent did not show a significant 
increase in the C-peptide level. Interestingly these were the very 
patients who required high doses of insulin for control. 
Although both the glucagon test and the glucose tolerance test was 
done in 15 patients, comparison between the responses of the two tests 
is not possible, since the 2 tests were done a few months apart in each 
of the cases. In addition, differences in the methods of C-peptide 
assay between the 2 tests would invalidate the significance of such a 
comparison. 
Studies on the correlation between insulin requirements and the basal 
or maximal C-peptide levels have yielded conflicting results (Faber and 
Binder 1977a, Grajwer et al 1971; Ikeda et al 1975). In this study an 
inverse correlation could not be established over the entire range of 
insulin doses and C-peptide concentrations. In fact there were some 
patients who had low C-peptide levels and yet needed relatively small 
doses of insulin and were controlled satisfactorily, confirming the 
view that a low level of the hormone is not necessarily associated with 
poor control (Grajwer et al 1971; Ikeda et al 1975). On the other 
hand it would appear that insulin dosage might bear a close relation-
ship with an absent C-peptide response to stimuli like glucagon. This 
is borne out by the large amounts of insulin needed for control in the 
patients who failed to respond to glucagon or glucose. 
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Although some workers have observed an inverse correlation between the 
degree of beta cell function and the duration of diabetes (Faber and 
Binder 1977b; Grajwer et al 1971; Madsbad et al 1978), such a 
relationship could not be shown in this study; most probably because 
in the majority of patients studied the disease was present for a short 
period only (mean duration 4 years). Nevertheless, if 5 years is 
taken as the cut off level for duration of diabetes then over 90% of the 
patients whose duration of disease fell within this period had 
residual beta cell function as judged by detectable C-peptide levels, 
whereas the prevalence in those with a longer duration of illness was 
60%. In other series the prevalence of detectable C-peptide levels 
has also been very high (over 75%) in patients whose diabetes was 
present for 5 years or less, whereas it was only 11% - 20% in those 
with a longer duration of disease (Grajwer et al 1971; Hendriksen 
et al 1977; Ludvigsson and Heding 1976). 
The positive correlation found between basal C-peptide levels and age 
of onset of diabetes has been observed in other studies (Ludvigsson 
and Heding 1976; Madsbad et al 1977). Thus it would appear that the 
older the patient is at the time of presentation of IDDM, the greater 
the degree of residual beta cell function. 
The significantly lower basal and maximal C-peptide levels observed in 
the African patients after glucagon provocation may reflect a greater 
degree of beta cell destruction in them as compared to the Indian 
patients. However it is also possible that the African patients have a 
lesser degree of beta cell function even before the development of IDDM. 
The fact that the basal and maximal C-peptide levels, though being 
lower in Africans, did not show significant differences between the 
2 control groups would tend to negate this hypothesis. On the other 
hand significantly lower maximal C-peptide levels seen in African 
controls during the glucose tolerance test would tend to favour such 
a possibility. 
The lack of a significant difference in the C-peptide levels after a 
glucose load between Africans and Indians with IDDM may seem surprising 
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in the light of the differences shown during glucagon provocation. 
A possible reason to explain this paradox is that the African patients 
undergoing the glucose tolerance test had a much shorter duration of 
IDDM (mean 3.3 years) compared to the Indian patients (mean 8 years) 
and hence any difference in C-peptide level may be offset by differences 
in duration of disease. Duration of disease in patients undergoing 
the glucagon test, however, was similar between the two groups and 
hence the difference assumes great significance. 
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SUMMARY 
Residual beta cell function based on C-peptide assays was estimated in 
35 young patients with IDDM and 22 controls using glucagon as a pro-
vocative agent, and in 45 insulin dependent diabetic patients and 18 
controls using glucose as a stimulus. The basal and 6 minute post-
glucagon C-peptide levels were significantly lower in the diabetic 
patients compared to controls. Residual beta cell function as gauged 
by the presence of significant C-peptide increments in response to 
glucagon was present in most patients. The diabetic patients showed 
significantly lower maximal C-peptide values and far more delayed peak 
levels compared to controls. Just over 10% of patients had no residual 
beta cell function as gauged by undetectable basal C-peptide levels 
which failed to rise after a glucose load. A significant correlation 
was seen between the age of onset of IDDM and the fasting C-peptide 
levels. No correlation was seen between the fasting or maximal C-
peptide levels; and the daily insulin requirements, duration of insulin 
therapy and fasting plasma glucose. C-peptide levels tended to be 
lower in Africans compared to Indians. 
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CHAPTER VI 
INSULIN RESPONSE TO ORAL GLUCOSE IN YOUNG 
NONINSULIN-DEPENDENT DIABETIC PATIENTS 
INTRODUCTION 
Studies of endogenous insulin secretion in response to a glucose load 
have shown significantly delayed and lower increments in most young 
noninsulin-dependent diabetic patients. (Fajans et al 1976; Fajans 
et al 1978; Johansen 1973). However, there is a marked variation in 
the magnitude of the individual responses (Fajans et al 1978) just as 
has been found in late onset NIDDM (Asmal and Leary 1975; Fajans et 
al 1974; Fajans et al 1976). Lower levels of insulin have been found 
in late onset noninsulin-dependent African patients when compared to 
similar Indian patients (Asmal and Leary 1975). 
MATERIALS AND METHODS 
Twenty healthy medical students comprising 10 Africans and 10 Indians 
with an equal sex distribution in each group and 48 young noninsulin-
dependent diabetic patients participated in the study. The mean age 
and weight of the healthy subjects were 23 years and 57 Kg respectively. 
The diabetic patients all had the disease before the age of 35 and 
included 14 Africans and 24 Indians. They formed part of the group 
described in Chapter IV. Table 1 shows the clinical characteristics of 
the patients studied. 
In patients on oral hypoglycaemic agents, the drugs were discontinued 
at least 72 hours before the clinical investigations were carried out. 
Patients and healthy subjects were studied in the morning after an 
overnight fast. They remained seated throughout the procedure and were 
not permitted to eat, chew or smoke. Informed consent was obtained 
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TABLE 1 CLINICAL CHARACTERISTICS OF THE PATIENTS 
Number of patients 
Male : female ratio 
Mean weight in Kg (range) 
Mean age in years (range) 





















from all the subjects. Indwelling cannulae were introduced into ante 
cubital veins under local anaesthesia and kept patent with slow in-
fusions of 0.9% Na CI. After a rest period of 30 minutes blood samples 
for basal glucose and insulin levels were collected. A drink of 100 gm 
glucose dissolved in 300 ml water was then given slowly. Blood for 
glucose and insulin was taken at 15, 30, 45, 60, 90, 120 and 150 
minutes after the first sip of glucose. 
Glucose was estimated using an autoanalyser and insulin levels were 
done by radioimmunoassay using Phadebas kits. The "insulinogenic index" 
or insulin : glucose ratio was obtained by dividing the plasma insulin 
increments above fasting value by the corresponding net increase in 
plasma glucose, (Seltzer et al 1967). 
RESULTS 
The individual insulin concentrations of all patients and controls 
during the GTT are depicted in Figure 1. 
The mean basal level in the controls is 24.7 ĵ  3.3 uu/ml rising to a 
mean maximum value of 129.2 +_ 15.3 uu/ml, Figure 2. This represents 
almost a 5 fold increase over the basal level and is highly significant 
(p < .0005). Although the mean basal insulin levels are higher in the 
African (29.1 +_ 5.4 uu/ml) than Indian controls (20.8 +_ 3.7 uu/ml) , 
the difference is not significant, Figure 3. 
The diabetic patients show a mean basal insulin level of 20.2 +_ 1.7 
yu/ml which rises by 120% to a mean maximum value of 48 +^6.6 uu/ml, 
Figure 2. The difference between the basal and maximal values is 
highly significant (p < 0.0005). The mean maximal insulin level in 
the diabetic patients is significantly lower than in the controls 
(p < 0.0005). The mean percentage elevation in insulin is also signi-
ficantly lower in the diabetic patients (p < 0.01). The peak insulin 
response occurred significantly later in the diabetic patients (mean 
84.6 minutes) when compared to controls (mean 46 minutes), p < 0.005, 
Figure 4. The controls show a greater and more rapid rise in the 
insulin : glucose ratio compared to a much slower rate and magnitude 
of increase in the diabetic patients, Figure 5. 
Figure 1. 
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THE PLASMA INSULIN RESPONSE DURING A GTT IN PATIENTS 
WITH NIDDM AND CONTROLS 
• Africans mean 
















a A A O o 
A 











A A A Q 






• • • 
o 
o 
Looo , oo w -©-
k 00 













• A „ 
• * ft 





•? °o° t oo 
o°o 
V 
-5J 15 30 
100 g glucose 




THE FASTING AND MAXIMAL PLASMA INSULIN RESPONSES 




















COMPARISON OF THE PLASMA INSULIN RESPONSES TO A 




























"^——$, »A Controls 
0 - 4 - ! 1 1 r 
g loo-















"̂ T - 5 
i i i i 
15 30 45 60 90 
•i 
120 150 
100gm Time minutes 
glucose 
e 4. 
THE PLASMA INSULIN AND GLUCOSE 
CONCENTRATIONS (mean±SE) DURING 

























90 -5 15 30 45 60 





THE INSULINOGENIC INDEX IN PATIENTS WITH NIDDM 
AND CONTROLS 











There is no correlation between the basal glucose levels and the 
maximal insulin levels, Figure 6. 
Duration of NIDDM also shows no correlation with the basal or maximal » 
insulin levels, Figure 7. 
The African patients show significantly lower basal insulin levels 
(mean 14.8 +_ 2.1 yu/ml) compared to Indian patients (mean 23.3 +̂  2.1 
u/ml), p < 0.01, Figure 2. Although the mean maximal value is also 
lower in the former group (35.7 ĵ  8.3 yu/ml) compared to the latter 
(mean 54.9 +̂  8.9 yu/ml), the difference falls short of statistical 
significant (p < 0.1). The Indian patients show significantly 
higher insulin values at 30, 45, 60, 90, 120 and 150 minutes than the 
African patients, Figure 3. 
The insulinogenic indices in the 2 race groups show that plasma insulin 
rises relatively higher in Indians with NIDDM (p < 0.01), Figure 8. 
Only 2 African patients showed a maximal insulin level of greater than 
50 yu/ml compared to 10 Indian patients. 
The 2 racial groups do not show any significant differences in the 
plasma glucose values taken at various points of the glucose tolerance 
test, Figure 3. 
DISCUSSION 
In this study it has been clearly shown than NIDDM in young Africans 
and Indians is characterised by a blunted and delayed insulin response 
to a glucose load and that in this respect it does not differ much 
from the pattern reported by Asmal and Leary (1975) in older non-
insulin-dependent diabetic patients belonging to the same race groups. 
Fajans et al (L976); Fajans et al 0.978) have also observed a similar 
insulin response in most of their young patients with NIDDM. Studies 
by Panzram and Adolph (1981) showed similar patterns of insulin 
secretion in younger and older patients with NIDDM. 
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Figure 6. 
THE CORRELATION BETWEEN FASTING PLASMA GLUCOSE AND MAXIMAL 
PLASMA INSULIN LEVELS IN PATIENTS WITH NIDDM 
• Fasting insulin r- 0.06 p MS. 
o Maximal insulin r=-0.36 p<0.05 
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Heterogeneity of insulin responses to glucose shown by wide variations 
in the individual patterns is a recognised feature of NIDDM in the young 
(Fajans et al 1976 , Fajans et al 1978) and in the older age group 
(Kobberling 1976). Thus the wide spectrum of insulin responses that 
was observed in the Indian patients in particular is not at all surpris-
ing. 
The lower insulin levels observed in African patients as a group com-
pared to Indian patients points to the existence of racial differences 
in the pattern of insulin secretion in NIDDM in the young. This dif-
ference is accentuated by the greater mean weight of the African com-
pared to the Indian patients. Asmal and Leary (1975) have also observed 
a more attenuated insulin response in older Africans with NIDDM compared 
to a similar group of Indians with the disease. Low insulin responses 
to a glucose load in Africans with NIDDM have been well documented in 
previous studies, (Keller et al 1972; Shires et al 1978; Wicks and 
Jones 1973). Even in White Caucasians Fajans et al (1978) observed a 
familial aggregation of patients, with low insulin response in some 
families and high responses in others. These observations suggest 
that racial and genetic factors play a part in delineating subgroups 
within the broad entity of NIDDM on the basis of insulin responses. 
The lack of a significant difference in insulin levels between African 
and Indian controls is at variance with the findings of Rubenstein et 
al (1969) who found lower levels in normal Africans compared to 
Indians and of Wapnick et al (1972) who found an attenuated response 
in healthy African cleaners compared to whites. On the other hand 
Keller et al (1972) observed similar insulin levels in healthy Cape 
Africans and Indian students, whilst Wapnick et al (1972) found higher 
values in healthy African students compared to African cleaners. 
Since the controls used in this study were nearly all students, it is 
quite possible that differences among the various studies are based on 
variations in the category of the control groups selected. 
Despite markedly decreased insulin responses the African patients show 
similar plasma glucose values to the Indian patients. In healthy 
African subjects also normal glucose homeostasis in the presence of 
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attenuated insulin responses has been observed (Rubenstein et al 1969, 
Wapnick et al 1972) . 
The lack of a significant correlation between the fasting plasma 
glucose and the fasting or maximal insulin level, which was also ob-
served by Asmal and Leary (1975) in older patients, is not unexpected 
in the light of recent evidence implicating defects at the receptor 
level rather than insulin secretion per se in the pathogenesis of 
NIDDM, (Olefsky and Reaven 1974; 1976). Nevertheless, Fajans et al 
(1976) did observe higher mean glucose levels in patients with low 
insulin responses, particulary at the time of diagnosis. 
The lack of correlation between duration of NIDDM and the individual 
insulin responses suggest that over a short period of time a decline in 
beta cell function may not be seen with increasing duration of disease, 
as has been found in IDDM. Similar observations have been made by 
Fajans et al (1976) who found that although 90% of their young patients 
with NIDDM had subnormal and delayed insulin responses to glucose, many 
of them did not show any deterioration in the responses over periods of 
up to 12 years. Therefore it would appear that it is the pattern of 
insulin response in, rather than the duration of, NIDDM that determines 
progression to insulin dependence, as had been found by Fajans et al 
(1976); Johansen (1971, 1973); Rosenbloom et al (1973). 
SUMMARY 
The insulin response to an oral glucose load was studied in 24 Indian 
and 14 African patients with NIDDM and 20 controls. The maximal insulin 
levels attained during the glucose tolerance test were significantly 
lower, and the peak insulin response occurred later in the diabetic 
patients compared to controls. The insulinogenic indices were also 
much lower in the patients. African patients showed lower basal and 
maximal insulin levels and lower insulinogenic indices than Indian 
patients, despite similar plasma glucose values. No correlation was 




BASAL HORMONAL AND LIPID PROFILE IN 
YOUNG DIABETIC PATIENTS 
INTRODUCTION 
The role of hormones other than insulin in the pathogenesis of diabetes 
or its complications has been the subject of much debate. The bihor-
monal theory of the pathogenesis of diabetes mellitus, viz: too little 
insulin and inappropriate or exaggerated secretion of glucagon, first 
propounded by Unger et al (1970) and later supported by Gerich (1976) 
held sway until recently. However, studies by Barnes et al (1975), 
Lundbaeck et al (1976), Sherwin et al (1976, 1978) provided enough 
evidence to refute this hypothesis. For instance, infusion of large 
amounts of glucagon into maturity or juvenile onset diabetics had very 
little, if any, adverse affect on diabetic control (Sherwin et al 1976). 
Similarly although elevated levels of growth hormone have been found in 
many diabetic patients (Molnar et al 1968; Prange-Hansen A. 1970, 1971, 
1973; Unger et al 1965) , others have found normal values (Baker et al 
1969; Luft and Cerasi 1968). Thus the latter came to the conclusion 
that growth hormone is diabetogenic only in such instances where the 
beta cells show an inherited defect in responding to the insulinogenic 
effect of growth hormone and in producing adequate quantities of 
insulin. Whilst growth hormone has also been implicated in the patho-
genesis of some of the complications of diabetes, notably retinopathy,-
(Knopf et al 1972), any direct line of evidence to support this hypo-
thesis is lacking (Luft and Guillemin 1974). 
The role of plasma lipids in accelerating atherosclerosis in diabetic 
subjects can also be seen in a similar light (West 1978). In 
Framingham Garcia et al (1974) could not find any significant differences 
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in cholesterol and triglyceride levels between diabetics and controls. 
Bowyer et al (1974) and Westlund and Nicolaysen (1972) came to the same 
conclusion. However, Chase and Glasgow (1976) and Wilson et al (1970) 
observed elevated lipid levels in Caucasian diabetics. Whilst high 
levels of lipids have been found in Indian (Asmal and Leary 1975) and 
African diabetics (Shapiro et al 1973) such investigations have been 
done mainly on older diabetic patients. Data on lipid levels in young 
African and Indian diabetics are at best scanty. 
MATERIALS AND METHODS 
The diabetic patients studied all had the disease before the age of 35. 
They included patients with IDDM, patients with NIDDM and patients who 
presented with NIDDM but later became insulin dependent. All patients 
formed part of the groups mentioned in Chapters III and IV. None of 
the patients had had ketosis in the previous 2 months. Blood samples 
for glucagon, growth hormone, Cortisol, cholesterol and triglyceride 
were taken in the basal state, after an overnight fast of 12 - 14 hours. 
Blood samples for glucagon were taken in tubes containing 9 mg of 
EDTA-Na. 3 000 Iu of Trasylol was added as soon as the blood was 
taken and the samples were immediately centrifuged, after which the 
plasma was kept frozen until the time of assay. 
Glucagon, growth hormone and Cortisol were measured by radioimmuno-
assay (Biodata diagnostica, Serono Laboratories, England for glucagon and 
Gamma Coat and Phadebas Kits respectively for Cortisol and growth 
hormone). Cholesterol and triglyceride concentrations were measured 
enzymatically• 
RESULTS 
Glucagon: Glucagon levels were estimated in 40 patients with IDDM 
(27 Africans, 13 Indians), 16 patients with NIDDM (14 Indians, 2 
Africans), 7 patients presenting with NIDDM but later requiring insulin 
and 18 healthy controls (9 Africans, 9 Indians). The mean basal 
glucagon levels in the various groups of diabetics and controls are 
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depicted in Figure 1. There is no significant difference in the mean 
glucagon levels betwen African and Indian controls. The basal levels 
in controls (mean 159 +_ 25 pg/ml) are significantly lower than in 
patients with IDDM (mean 306 +_ 26 pg/ml, p < 0.0005), NIDDM (mean 
270 +_ 28 pg/ml, p < 0.005) and NIDDM prgressing to insulin-dependent 
diabetes (mean 385 + 7 ) , p < 0.0005). 
Although the Indian patients with IDDM show higher glucagon values 
(mean 313 +_ 45 pg/ml) than their African counterpart (mean 303 +_ 33 
pg/ml), the difference is not significant. Similarly there is no signi-
ficant difference in glucagon values between patients with IDDM and 
NIDDM. 
The highest mean glucagon levels was seen in the patients initially 
noninsulin-dependent but later requiring insulin for control. 
Growth Hormone: Growth hormone assays were done on 67 patients with 
IDDM (46 Africans, 21 Indians); 34 patients with NIDDM (7 Africans, 
27 Indians); 14 patients progressing from NIDDM to insulin-dependence 
and 18 controls. 
The mean basal growth hormone levels in the various groups of diabetics 
and controls are depicted in Figure 2. The patients with IDDM show 
significantly higher levels (mean 2.32 +_ 0.31 ng/ml) than controls 
(mean 0.71+_ 0.23 ng/ml), p < 0.01. However, the values in patients 
with NIDDM (mean 1.82 +_ 0.52 gn/ml) do not show a significant difference 
from the control values. In patients and controls there are no signi-
ficant differences in growth hormone levels between Africans and Indians. 
The mean value in patients with retinopathy (1.67 +_ 0.44 ng/ml) showed 
no significant difference when compared to those without this compli-
cation (mean 2.31 +_ 0.30 ng/ml). 
Cortisol: Cortisol levels were estimated in 82 patients with IDDM (59 
Africans, 23 Indians); 52 patients with NIDDM (9 Africans, 27 Indians); 
16 patients with NIDDM progressing to insulin dependence; and 18 
controls (9 Africans, 9 Indians). 
Figure 1 
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THE BASAL PLASMA GLUCAGON CONCENTRATIONS (mean±SEM) 
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The mean Cortisol levels in the various groups of diabetics and controls 
are shown in Figure 3. Although the mean value seen in controls 
(12.24 + 1.2 ug/ml) is lower than the means in patients with IDDM 
(14.23 +_ 0.7 yg/ml), NIDDM (13.2 +_ 0.7 ug/ml) and NIDDM progressing to 
insulin-dependence (12.24 +_ 1.26 ]ig/ml) the differences are not 
significant. Similarly the levels among the various groups of 
diabetics do not differ significantly from one another. In addition 
there were no racial differences in Cortisol levels among patients 
and controls. 
Cholesterol; Plasma cholesterol concentrations were measured in 98 
patients with IDDM (73 Africans, 25 Indians); 55 patients with NIDDM 
(16 Africans, 32 Indians); 17 patients presenting with NIDDM but 
later becoming insulin-dependent (all Indians); and 17 controls (9 
Africans, 8 Indians). 
The mean cholesterol concentrations in the various groups of diabetic 
patients and controls are depicted in Figure 4. The mean value in 
controls (4.19 +_ 0.23 mmol/L) is significantly lower than in patients 
with IDDM (mean 5.10 +_ 0.18 mmol/L, p < 0.025); NIDDM (mean 5,23 +_ 
0.59 mmol/L, p < 0.025); and NIDDM progressing to insulin-dependence 
(mean 5.44 +_ 0.31 mmol/L, p < 0.05). 
The Indian patients with NIDDM show significantly higher cholesterol 
levels (mean 5.50 +_ 0.28 mmol/L) than the Indian controls (mean 4.39 +_ 
0.44 mmol/L), p < 0.05. Those with NIDDM (mean 5.25 mmol/L +_ 0.59) 
also show a significant difference compared to controls, p < 0.025. 
There is no significant difference seen between African controls 
(mean 3.98 +^0.17 mmol/L) and African patients with IDDM (mean 4.95 +_ 
0.22 mmol/L). The African patients with NIDDM, however, show signi-
ficantly higher cholesterol values (mean 5.15 +_ 0.36 mmol/L) compared 
to the African controls, p < 0.025. Although the mean cholesterol 
levels were higher in the Indian patients with IDDM and NIDDM when 
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Triglyceride: Plasma triglyceride concentrations were done on 89 
patients with IDDM (63 Africans, 29 Indians), 41 patients with NIDDM 
(10 Africans, 31 Indians), and 17 controls (9 Afircans, 8 Indians). 
The mean plasma triglyceride levels in the various groups of diabetic 
patients and controls are depicted in Figure 5. The mean value seen 
in the controls (1.27 j^0.73 mmol/L) is significantly lower than in 
patients with NIDDM (mean 3.07 +_ 0.60 mmol/L, p < 0.05). However, 
the levels in patients with IDDM (mean 1.92 +̂  0.20 mmol/L) do not 
differ significantly from those in controls. Similarly patients with 
NIDDM progressing to insulin dependence (mean 2.68 + 0.47) do not show 
a significant difference from the controls. 
Although African patients with IDDM show a lower mean triglyceride 
level (1.79 +_ 0.24 mmol/L) than the Indian patients (mean 2.24 +_ 
0.30 mmol/L) the difference is not significant. In patients with NIDDM 
also no significant difference is seen between the 2 racial groups. 
The mean triglyceride concentration in African controls (0.91 +^0.10 
mmol/L) is lower than that in Africans with IDDM, but the difference 
falls short of statistical significance. The Africans with NIDDM, 
however, show significantly higher values (mean 1.76 +^0.27 mmol/L) 
than African controls, p < 0.01. 
Indians with IDDM and NIDDM, although showing higher mean levels 
(2.20 +_ 30 mmol/L and 3.49 +_0.78 mmol/L respectively) do not differ 
significantly from Indian controls (mean 1.63 j^0.34 mmol/L). 
Comparison of the 2 control groups shows that the Indians have signi-
ficantly higher triglyceride levels than the Africans, p < 0.05. 
DI SCUSSI0N 
The status of diabetes is affected in some way or the other by almost 
all hormones (Williams 1972). Although it is well known that per-
manent diabetes may result from administration of large amounts of 
growth hormone, glucocorticoids or glucagon and that less insulin is 
Figure 5. 
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THE PLASMA TRIGLYCERIDE CONCENTRATIONS 
(mean ±SEM) IN THE DIABETIC PATIENTS AND 
CONTROLS 
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required for control of diabetes in the absence of growth hormone, 
Cortisol or glucagon (Williams 1975), their role in the aetiology of 
primary diabetes is obscure. 
The markedly elevated glucagon levels found in the diabetic subjects 
compared to controls have been observed in several studies (Aguilar-
Parada et al 1969; Alford et al 1976; Day and Anderson 1973; 
Heding and Rasmussen 1972) . That this elevation probably represents a 
true excess of secretion in the diabetic patients is supported by the 
work of Alford et al (1976) who found that the metabolic clearance of 
glucagon is not decreased in diabetic subjects. 
High levels of glucagon in non ketotic diabetic patients, as has been 
observed in the patients with NIDDM described in this study, led 
Alford et al (1976) to speculate that this hormone may be responsible 
for the decreased effectiveness of circulating insulin which was thought 
to be the mechanism operating in non-ketotic diabetes (Reaven et al 
1976). However, Olefsky et al (1977) found no difference in glucagon 
levels between normal and diabetic subjects and therefore discounted 
the role of this hormone in causing insulin resistance. 
Whilst the unequivocal demonstration of elevated glucagon levels in the 
African and Indian diabetic patients in this study may appear to sup-
port linger's bihormonal hypothesis in the causation of diabetes most 
evidence now suggest that hypergluconaemia is a result of the impaired 
metabolic balance seen in this disease (Assan et al 1969; Matsuyama 
et al 1975; Muller et al 1973; Pek 1977). Relatively lower glucagon 
levels have been observed in patients treated with sulphonylureas 
compared to those on insulin (Loreti et al 1974; Ohneda et al 1975). 
Such a trend was also observed in this study, since insulin-dependent 
diabetic patients tended to have higher values than those with NIDDM. 
Elevated growth hormone levels in diabetes, which were observed in this 
study, have been found by various workers (Burday et al 1968; Molnar 
et al 1972). However, other studies have shown normal levels of this 
hormone in diabetes, particularly in children, (Baker et al 1967; 
Baker et al 1969; Parker et al 1967). Thus the role of growth hormone 
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itself in the pathogenesis of diabetes mellitus can be seriously 
questioned. Another drawback to such a hypothesis is that in acro-
megaly only a minority of patients develop diabetes mellitus despite 
the marked increase in growth hormone production. 
Based on the observations that patients with retinopathy have high 
growth hormone levels (Rnopf et al 1972; Knowles 1975) and that hypo-
physectomy may ameliorate this condition, this hormone has been impli-
cated in the pathogenesis of such complications. However, the fact 
that acromegalic patients are relatively free of angiopathy argues 
against such a postulate (Luft and Guillemin 1974). In this study the 
mean growth hormone level in patients with retinopathy was lower than 
in those without this complication, although the difference was not 
significant. Thus the findings in this study are at variance with 
those of Knopf et al (1972) who observed higher growth hormone levels 
in patients with retinopathy. 
Elevated growth hormone levels and normal Cortisol values in Indians 
with NIDDM provide enough scientific evidence to refute Campbell's 
postulate (made without any scientific evidence) that the young Natal 
Indian diabetic suffered from a form of diabetes characterised by a 
relative insulin deficiency, overproduction of glucocorticoids and 
relative lack of growth hormone. (Campbell 1960; Campbell and 
McKechnie 1961). 
Although earlier work suggested that the secretion of adrenal hormones 
was considerably higher in diabetics compared to controls (Forbes et 
al 1947; Fraser et al 1941; Miller and Mason, 1945), subsequent studies 
did not confirm this finding (Dancaster et al 1963). 
The mean cholesterol and triglyceride levels in African controls are 
almost identical to the values found in a group of adolescent African 
girls by Walker et al (1980). The lack of significant difference in 
cholesterol levels between the small numbers of African and Indian 
controls is not entirely unexpected, since Walker (1973) also found 
similar mean values between urban Indians and urban African teachers 
and clerks in a study involving a fairly representative group of 
healthy adults between the ages of 30 to 39. 
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Although the cholesterol levels were higher in the diabetic patients 
compared to controls, the mean values would, according to Walker's ob-
servations (Walker 1966), be well within the normal range for these 
population groups. Taking 5.78 mmol/L as the cut-off point, Walker 
(1973) found that 25% of healthy urban African and 55% of healthy 
Indians had a cholesterol concentration in excess of that figure. 
In this study less than 20% of African and only 25% of Indian diabetic 
patients had a cholesterol level above 5.78 mmol/L. Similarly less 
than a third of African and Indian patients with NIDDM had higher 
values. Studies involving White Caucasians have also shown relatively 
normal levels of cholesterol in diabetic patients (Garcia et al 1974; 
Kenien et al 1977; Lundbaeck and Petersen 1953). In middle aged 
black diabetic patients also relatively low levels have been observed 
(Shapiro et al 1973). However, Asmal and Leary (1975) showed elevated 
levels in middle aged African and Indian patients, whilst others have 
found high values in White Caucasians with juvenile diabetes (Chase and 
Glasgow 1976; Sterky et al 1963). 
Elevated triglyceride levels in diabetes mellitus have been documented 
in numerous studies involving White Caucasians and older African and 
Indians with the disease (Asmal and Leary 1975; Shapiro et al 1973; 
Walker 1966; Wilson et al 1970). Similar findings have been observed 
in this study. NIDDM in Indians in particular appears to be associated 
with high triglyceride levels. 
Since the prevalence of large vessel disease was low in the patients 
studied, probably because of the relatively short duration of diabetes 
in most of them, it is difficult to draw any conclusions on the relation-
ship of serum lipids to such complications. 
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SUMMARY 
Basal glucagon, growth hormone, Cortisol, cholesterol and triglyceride 
concentrations were estimated in patients with IDDM and NIDDM and those 
initially presenting with NIDDM but later becoming insulin dependent. 
All the groups of diabetic patients showed significantly higher glucagon 
levels compared to controls. Higher growth hormone levels were found 
in the patients compared to controls, the difference being significant 
in those with IDDM. No significant difference in growth hormone levels 
were seen between those with and those without retinopathy. Mean 
Cortisol levels in the diabetic patients and the controls did not differ 
significantly from each other. There were no racial differences in the 
levels of these hormones among patients and controls. Although the mean 
cholesterol and triglyceride levels in the patients were significantly 




GLYCOSYLATED HAEMOGLOBIN LEVELS IN THE 
YOUNG AFRICAN AND INDIAN DIABETIC PATIENTS 
INTRODUCTION 
Haemaglobin A is a glycosylated haemoglobin formed by the binding of 
glucose to the N-terminal valine of the beta-chain of adult haemoglobin. 
The process is a non-enzymatic one, being dependent on the degree and 
duration of hyperglycaemia. Possessing the property of rapid mobility 
on electrophoresis, Hb A constitutes a minor component of adult 
haemoglobin. 
After Huisman and Dozy (1962) had observed elevated glycosylated levels 
in diabetic patients, several other groups reported on the correlation 
between diabetic control and haemoglobin A levels (Gabbay et al 1977; 
Gonen et al 1978; Koenig et al 1976). It soon became apparent that 
this haemoglobin moiety is a useful objective indicator of the inte-
grated plasma glucose level over prolonged periods of time (Gabbay 1976; 
Peterson et al 1977; Anon. 1977). Subsequently, however, it was 
shown that even short term fluctuations in blood glucose may alter 
Hb A levels, but in a reversible fashion. (Bolli et al 1981; 
KaramanOs et al 1977; Widness et al 1980). Thus the process of glyco-
sylation occurs in two ways, viz: a reversible one due to acute changes 
in blood glucose and an irreversible one due to chronic hyperglycaemia. 
(Franklin Bunn 1981). 
However, the difference between the glycosylated haemoglobin level that 
included the reversible component and the level consisting of the stable 
moiety only was relatively small, with the maximal fluctuation being 
not more than 1.5% over 2 - 1 2 hours (Bolli et al 1981; Botterman 
1981). Moreover, the maximal changes only occurred in the range from 
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14% to 15%, wheras at lower levels the differences were very small and 
only slightly above the range of error of methodology, (Botterman 1981). 
Thus it was concluded that in the clinical context greater fluctuations 
of glycosylated haemoglobin values in the range of 14% to 15% are of 
little significance because patients with such high values are already 
in poor control and require close attention regardless of any minor 
variations, (Botterman 1981). 
PATIENTS AND METHODS 
Ninety seven patients with insulin-dependent diabetes and twenty one 
patients with noninsulin-dependent diabetes were studied. All patients 
formed part of the group described in Chapter II. They were followed 
up regularly at the Diabetic Clinic of King Edward VIII Hospital. The 
age, race, sex, duration of diabetes and dose and frequency of insulin 
therapy were recorded for each patient, Tables 1 and 2. 
All patients were studied in the post-prandial state (between 08.00 
and 12.00). Venous blood was taken for estimation of HbA and plasma 
glucose in all the patients. Where more than one HbA levels were done, 
the mean value was recorded. In 80 patients at least 2 measurements 
were performed over a 12 month period. 
Plasma glucose was measured using an autoanalyser. HbA levels 
were measured using the Helena Glycosylated (Fast Fraction) Haemoglobin 
Quik Column Kit which utilises a microchromatographic technique for 
rapid quantitation of glycosylated haemoglobin. 
RESULTS 
The mean HbA level in a group of 49 healthy subjects was 7.50% +_ 0.49% 
(S.D.). The distribution of HbA levels in the patients with NIDDM and 
the insulin-dependent diabetic patients are depicted in Figures 1 and 2. 
The levels are significantly lower in patients with NIDDM (mean + SE _ 10.6 
_0.4%) than the insulin-dependent diabetic patients (mean 12.1% +_ 0.2%) 
p < 0.0025. There were 57 patients on a single daily dose of insulin 
and they had a mean HbA level of 11.75 +_ 0.29% respectively. In the 
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TABLE 1 CLINICAL CHARACTERISTICS OF THE INSULIN DEPENDENT 
DIABETIC PATIENTS 
Number of patients 
Male : female ratio 
Mean weight in Kg (range) 
Mean age in years (range) 
Mean duration of insulin 
therapy in years (range) 
Mean insulin requirement 
in Iu/Kg/day (S.E.) 
























1.33 + 0 
40 
.07 
TABLE 2 CLINICAL CHARACTERISTICS OF THE PATIENTS WITH NIDDM 
Number of patients 
Male : female ratio 
Mean weight in Kg (range) 
Mean age in years 
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40 patients on a twice daily insulin regime the mean HbA1 was 12.7 +_ 
0.24%. Twelve patients had a HbA level below 9% which is slightly 
higher than three standard deviations above the normal mean value. 
They comprised 5 patients with NIDDM (25%) and only 7 insulin dependent 
diabetic patients (7%). 
The African patients with insulin-dependent diabetes had a signifi-
cantly lower HbA level (mean 11.8% +. 3%) than their Indian counter-
parts (mean 12.4% +_ 3%). In addition, the random plasma glucose levels 
in the former (mean 12.9% +_ 0.9%) were significantly lower than in the 
latter (mean 15.2% +_ 1.1%) , p < 0.05. 
Hb A, and Beta Beta Cell Function 
In the insulin-dependent diabetic patients there is a significant 
negative correlation between the Hb A. levels and the maximal C-peptide 
concentrations attained during a GTT (r = - 0.47 p < 0.05), Figure 3. 
However no correlation is seen between the Hb A levels and the fasting 
C-peptide. In patients with NIDDM no correlation could be established 
between HbA.. levels and the fasting or maximal insulin levels observed 
during a glucose tolerance test, Figure 4. 
HbA.. and Duration of Diabetes 
In patients with both NIDDM and IDDM no correlation is seen between 
HbA1 values and the duration of diabetes• 
HbA and Type of Insulin-Dependent Diabetes 
In the 14 patients who initially presented as NIDDM but later required 
insulin, the HbA.. values (mean 12.5% +_0.5%) do not differ signifi-
cantly from those of patients who have always been insulin-dependent 
(mean 12.0% +_ 0.21%). 
Serial Measurements of HbA., 
In the 68 patients with IDDM who had HbA, values done more than once 
(at intervals of at least 2 months between consecutive estimations) 
during a one year period no change (defined as more than 1% above or 
below the initial value), (Gonen etal 1979), was seen in 10 patients. 
A decrease was observed in 43 patients whilst an increase was seen in 
THE CORRELATION BETWEEN HAEMOGLOBIN A, LEVELS AND FASTING AND MAXIMAL 
PLASMA C-PEPTIDE CONCENTRATIONS IN PATIENTS WITH IDDM 
• Fasting C-peptide r=0.16 p N.S. 
o Maximal C-peptide-GTT r = - 0 . 4 7 p < 0 . 0 1 
a Maximal C- peptide-glucagon test r- -0.10 p N.S. 
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only 2 patients. Among the 34 patients with an initial value of less 
than 14, no change was observed in almost 25% of them, whilst a decrease 
was observed in 50% and an increase in the remainder. 
HbA and Random Plasma Glucose Levels 
A significant correlation is seen between HbA.. levels and random 
plasma glucose concentrations taken at the same time, Figure 5. In 13 
patients there is a discrepancy between HbA levels and random plasma 
glucose concentrations. All of them showed poor control on the basis 
of HbA levels (mean 14.2% +^0.6%), but at the same time had glucose 
values in the near normal range. 
DISCUSSION 
The aim of therapy in diabetic patients is to control the blood glucose 
level to as near normal as possible. However, in practice this objec-
tive is achieved in very few patients as shown in recent studies, 
(Gonen etall979, Tchobroutsky et al 1980). 
Studies on metabolic control based on HbA. levels have highlighted the 
poor quality of diabetic control in insulin-dependent diabetic patients 
even in referral centres where the establishment of good metabolic 
control is of primary concern. Taking three standard deviations below 
the mean to be indicative of excellent control, Gonen et alia (1979) 
found that only 13% of their insulin-dependent diabetic patients fell 
into this category. A similar study done by Tchobroutsky et alia (1980) 
showed that 19% of their insulin-dependent diabetics could be regarded 
as being in excellent control. The results in this study show that a 
very small percentage (7%) of insulin dependent diabetic patients were 
found to be in excellent control (HbA < 9.0%). Even if a level of 
12% is arbitrarily chosen as the upper limit for acceptable though by 
no means good metabolic control, (Gonen et al 1979), then only 44% of 
the patients fell into this category. Thus the majority of the 
patients did not measure up even to a satisfactory standard of diabetic 
control. Several reasons could account for such findings. Firstly in 
many of our patients primary health care facilities are conspicuous by 
CORRELATION OF RANDOM PLASMA GLUCOSE CONCENTRATION AND THE PERCENTAGE 
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their absence. In some because of ponr-socio-economic status 
a diabetic diet is difficult to follow. Moreover, because of poor 
education other patients found it difficult to administer the correct 
dose of insulin. 
The significantly lower HbA levels in patients with NIDDM shown in 
this study has also been observed by others (Gonen et al 1979) and 
reflects the greater ease with which this type of diabetes can be 
controlled. 
As there was a significant negative correlationbetween HbA levels and 
maximal C-peptide concentrations it would appear that glycosylated 
haemoglobin estimations may provide a rough index of beta cell function 
in insulin-dependent diabetic patients. In patients with NIDDM, 
however, the absence of a significant correlation between HbA levels 
1 
and the maximal insulin value may point to a defect at the receptor 
level serving to accentuate the metabolic abnormality. 
The significance of serial estimations of HbA levels in this study as 
an indicator of improved metabolic control is hampered by the presence 
of reversibly glycosylated components of glycosylated haemoglobin 
that are formed by acute elevations of plasma glucose, (Bolli et al 
1980). However, since the reversible moiety only makes a significant 
contribution to the glycosylated haemoglobin level in the range 14% -
15% (Botterman 1981), sequential HbA levels in patients in whom 
initial values were less than 14% may provide a useful index of the 
ease with which metabolic improvement may be achieved. Thus a trend 
towards improvement was seen in only 50% of the insulin dependent 
diabetic patients, illustrating the difficulty with which good meta-
bolic control can be attained in IDDM. 
Tchobroutsky et al (1980) found a significantly lower HbA level in 
patients who were on a twice daily insulin regime. In this study, 
however, patients on a once daily insulin regime had a significantly 
lower HbA level than those on a twice daily regime. It is difficult 
to draw any conclusions from this, since in many of the patients 
(except the very young) a single daily dose of insulin therapy was instituted 
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initially and only if control was poor, were they changed to twice 
daily therapy. 
Although both the African and Indian patients reported in this study 
came from poor socio-economic background and hence found it difficult 
to follow a diabetic diet strictly, the former had significantly lower 
HbA and plasma glucose levels. A possible explanation for the dif-
ference is that the traditional African diet, which contains more 
fibre, itself helps improve glucose homeostasis. 
In patients who progressed from noninsulin-dependent diabetes to an 
insulin-dependent state, it would be expected that insulin requirements 
and glycosylated haemoglobin levels will be lower because of residual 
endogenous insulin secretion. This, however, was not the case in the 
13 patients who fell in this category. Their mean HbA level was not 
significantly different from the diabetic patients who were insulin 
dependent ab initio. 
The correlation demonstrated between single random glucose levels and 
HbA levels is encouraging, in view of the fact that it is still pro-
bably the most widely used test in assessing diabetic control. While 
the measurement of HbA has been used as a cumulative index of the 
adequacy of control of diabetic patients over given periods of time, 
several cautionary remarks have been made about its use as the sole 
arbiter of control, (Asmal 1980; Gonen et al 1979). For instance, it 
does not take into account the occurrence of hypoglycaemic episodes or 
daily fluctuations in plasma glucose levels. Thirteen patients 
exhibited such a phenomenon. Despite this drawback HbA.. estimation 
permits an easy assessment of what the mean blood glucose in a given 
patient has been in the preceding 2 - 4 weeks. In this way, particu-
larly in situations where reliance cannot be placed on regular urinaly-
sis or blood glucose values, comparison of HbA.. levels from visit to 
visit will allow an assessment of the quality of control. This aspect 
assumes particular importance in socio-economically deprived populations. 
The diabetic patients that attend the King Edward VIII Hospital are 
generally from poor socio-economic groups whose social and other 
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problems often prevent proper supervision of their disease at home. 
The urine results brought to the clinic may not be done accurately at 
home or are conjured up to satisfy the physician. The random blood 
glucose done when patients attend the clinic in the mornings suffer 
from the disadvantage that they are drawn at variable intervals after 
meals at different visits and do not provide any measure of certainty 




Glycosylated haemoglobin levels (HbA ) were measured in 97 insulin 
dependent and 21 non insulin dependent diabetic patients. Patients 
with NIDDM had significantly lower HbA.. levels compared to insulin 
dependent diabetic patients. Excellent control as gauged by a HbA, 
level below three standard deviations above the mean value (9%) was 
seen in 25% of patients with NIDDM and only 7% of the insulin dependent 
diabetic patients. A significant negative correlation was seen between 
maximal C-peptide levels attained during a GTT and the HbA levels in 
the insulin dependent diabetic patients. Random plasma glucose levels 
showed a sginificant correlation with HbA, levels. Serial measurement 
of HbA levels showed a trend towards improvement in 50% of patients. 
African patients had significantly lower HbA.. and plasma glucose levels 
compared to Indian patients. Poor socioeconomic conditions are probably 
responsible for the unsatisfactory state of metabolic control in the 
majority of patients. 
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CHAPTER IX 
THE HLA SYSTEM AND DIABETES -WELLITUS IN 
YOUNG AFRICANS AND INDIANS 
INTRODUCTION 
The HLA system, also known as the major histocompatibility system, 
constitutes a complex group of antigens located on the surfaces of 
all nucleated cells and platelets. These antigens are determined by 
genes located on the short arm of the sixth chromosome where they are 
closely linked with genes controlling various immune responses and 
some components of the complement cascade. HLA, A, B, C and D antigens 
are determined by four different loci, each with a large number of 
alleles. The recently described DR antigens are possibly controlled 
at the same locus as the HLA D antigens. An individual inherits one 
set of A, B, C, D and DR antigens (called HLA-haplotype) from each 
parent, usually without any recombination taking place (Platz et al, 
1978; Rotter et al, 1978; Rubinstein et al, 1977). As the 
genes are codominant, the phenotype of each individual may express 
two specificities of the A-locus, two of the B-locus,etc. (Nerup et al, 
1977). 
The HLA system is characterised by extreme polymorphism at each locus. 
In addition pronounced linkage disequilibrium occurs between the 
various loci, that is, certain pairs of HLA antigens are found together 
in a population in greater frequency than would be expected from multi-
plying their individual frequencies together. For example, as HLA Al 
at the A locus is found in about 16% of white Caucasians and HLA Bl at 
the B locus in about 13%, they would be expected to be found together 
in about 2% of the population. However, they are found together 10% 
of the time and therefore are in linkage disequilibrium (Bodmer and Thomson 
1977; McMichael and Mc Devitt 1977; .Rotter and Rimoin 1979). 
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There is considerable variation in the prevalence of specific HLA antigens 
among different population groups throughout the world (Dausset and Svejgaard 
1977; Hammond et al 1975; Hammond et al 1977; Menozzi et al 1978; 
Ryder et al 1978). 
In recent years numerous studies have shown clear associations between 
the HLA systems and various diseases, (Ryder et al, 1979). Although 
the mechanisms through which HLA antigens confer disease susceptibility 
are obscure, several hypotheses have been suggested: Christy et al 1979.) 
1. direct effects of the HLA antigens (e.g. interference with ligand-
receptor interaction on all surfaces). 
2. effects of different but closely linked or functionally related 
genes in the HLA region (e.g. immune response genes). 
3. effects of genes in linkage disequilibrium with HLA by pure co-
incidence, the HLA antigens here being 'inert' markers. 
The term relative risk (Woolf 1955) is used to indicate how much more 
frequently the disease in question occurs in carriers of a particular 
antigen as compared to those lacking this antigen. It refers to the 
strength (but not the statistical significance) of HLA and disease 
associations, (Christy et al, 1979). 
Studies on the possible association between the HLA system and diabetes 
were apparently undertaken almost simultaneously by several groups of 
investigators. Finkelstein et al (1972) could find no association 
between HLA and juvenile diabetes. Singal and Blajchman (1973) however, 
did show an increase of HLA BW15 in a small group of insulin dependent 
diabetic patients, but owing to technical difficulties their conclusions 
had to be interpreted with caution. It was Nerup et al (1974a) who 
finally produced definite evidence to show a relationship between IDDM 
and the presence of HLA B8 and BW15. Not long after, Cudworth and 
Woodrow (1974) confirmed these findings. Since then many studies, 
using two approaches, viz: population studies and family studies, have 
provided unequivocal evidence in support of an association between 
IDDM and the HLA system. 
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The antigens associated with IDDM in White Caucasian populations 
include HLA C3, C4, B8, B15, B18, DW3, DW4, DR W3 and DR W4. HLA B7 
and DW2, however, show a negative correlation with IDDM (Christy et al 
1979). None of the studies on White Caucasians has found an association 
between NIDDM and HLA antigens (Christy et al 1979; Nelson and Pyke 1975). 
Data on the relationship between diabetes mellitus and the HLA system 
in non-Caucasian populations are scanty (Christy et al 1979a). However, 
they do show definite associations between IDDM and certain HLA antigens. 
In the Japanese the disease has been associated with HLA DYT and HLA 
BW54 (Kawa et al 1977; Nakao et al 1977; Okimoto et al 1978), whilst 
in American Blacks an association with DR3 and DR4 has been shown. 
(Duquesnoy et al 1979; Rodey et al 1979). It is thus evident that 
there are differences in the specific allelic associations among 
various ethnic groups. 
In this chapter the association between diabetes mellitus and the HLA 
system in Africans and Indians will be described. 
MATERIALS AND METHODS 
HLA A, B and C antigens were determined on 208 patients who were 
classified as follows: 
Insulin-dependent (always): 70 Africans 
56 Indians (29 Dravidians and 27 Aryans) 
Noninsulin-dependent initially later becoming insulin-dependent: 
7 Africans 
14 Indians 
Noninsulin-dependent: 61 Indians (33 Dravidians and 28 Aryans) 
The Aryans originated from North India and the Dravidians from South 
India. DR specificities were determined on 53 diabetic patients of 
whom 30 were Africans (always insulin-dependent) and 23 were Indians. 
In the latter group 16 patients had always depended on insulin for 
control of symptoms and 7 were initially controlled on oral agents 
but later required insulin. 
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The frequencies of the HLA antigens were compared to a group of 
healthy controls comprising 1 000 Africans and 768 Indians (271 
Aryans and 497 Dravidians), in all of whom HLA A, B and C antigens were 
determined. HLA DR antigens were determined in 118 African controls 
and 73 Indian controls. 
A total of 180 antisera were used in a two-stage microlymphocyto-
toxicity test to determine HLA A, B and C specificities. Lymphocytes 
were isolated on a Ficoll-Hypaque density gradient, (Boyum 1968). 
HLA DR specificities were determined by means of an extended incubation 
microlymphocytotoxicity test using T cell depleted B cell enriched 
lymphocytes. 
The frequency differences between the patients and controls were 
tested for significance by means of the chi-square test (without 
Yeates' correction). (Woolf 1955). The resulting probabilities were 
multiplied by the the number of specificities tested in order to deter-
mine the corrected P value (Svejgaard et al 1974). 
Relative risk was calculated according to the method of Woolf (1955) : 
Number of patients positive x Number of controls -ve 
Number of patients negative x Number of controls +ve 
RESULTS 
Tables 1 and 2 shows the antigen frequencies in the African patients 
with IDDM and the African controls. 
IDDM and HLA Antigens in Africans 
At the A and C loci there is no significant difference in the frequency 
of any of the antigens between the African patients with IDDM and the 
African controls. The frequency of HLA B8 is increased in the African 
patients with IDDM compared to the controls (21,4% vs 14,1%) but this 
was not significant after correcting for the number of antigens being 
tested. Similarly the frequency of HLA B14, although increased in the 
Africans with IDDM (15,7% vs 6,22%), does not attain a significant 
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Since HLA B8 and B14 form a part of a cross reacting group of antigens, 
the presence of either of these antigens in the patients was compared 
to that in the controls. The difference is highly significant even 
after correction for the number of antigens tested (37,1% vs 19,7%), 
Pc < 0,02. 
There appears to be a negative correlation between the presence of HLA 
BW42 and IDDM in Africans, since it was found in 25.5% of controls and only 8.4% of 
patients. However, the corrected p value fails to attain a level of 
significance. At the DR locus IDDM in Africans is associated with a 
significant increase in the frequency of DR4 (36,7% vs 9,3%), Pc < 0,04. 
IDDM and HLA Antigens in Indians 
Tables 3 and 4 shows the antigen frequencies in the Indian patients with 
IDDM and the Indian controls. At the A locus there is an increase in 
the frequency of HLA AW24 in those with onset of IDDM under the age of 
20 (51,3% vs 27,6%). However after correction for the number of antigens 
the difference falls short of statistical significance. At the B locus 
there is a significant increase in the frequency of B8 (21,4% vs 6,1%) 
Pc < 0,02. 
Comparison between the 2 subgroups, viz: Aryans and Dravidians, shows 
that the relative risk is higher in the former group (4,9 vs 3,6) and 
that the relationship between IDDM and HLA B8 fails to attain a statis-
tical significance in the latter group after correcting the p value, Table 5. 
The Aryans, however, show a significant increase in HLA B8 even after 
correction has been made for the number of antigens being tested. 
There are no differences in the frequencies of any of the antigens at 
the C Locus. 
The frequency of DR4 is significantly increased in the Indians with IDDM 
(43,8% vs 10,8%), Pc < 0,04. 
NIDDM and HLA Antigens in Indians 
Table 6 shows the antigen frequencies in the Indian patients with NIDDM 
and the Indian controls. In the Indian patients with NIDDM there is a 
significant increase in the frequency of HLA BW61 (41% vs 16,8%) Pc < 0,02. 
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*P < 0.005 
*Pc < 0.02 
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Pc < 0.02 
Pc < 0.04 
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NIDDM Progressing to Insulin-Dependent Diabetes Mellitus and HLA 
Antigens in Africans and Indians 
Table 7 shows the antigen frequencies in the patients who were initially 
noninsulin-dependent but later became insulin-dependent. It is diffi-
cult to draw any conclusions about their relationship to the HLA system 
because of the small number of patients tested. Nevertheless there is 
certainly no preponderance of HLA B8 or BW 61 or B14. 
DISCUSSION 
In W'hite Caucasians two distinct forms of IDDM have been recognised and 
these may be distinguished on the basis of HLA studies (Rotter and 
Rimoin 1978). There is an auto-immune variety which is associated with 
DW3 and less strongly with B8; the presence of islet cell antibodies 
(Morris et al 1976; Nerup et al 19Z7), an increased risk of micro-
angiopathy (Barbosa et al 1976; Bottazzo et al 1978; Schernthaner et 
al 1976). The other type, which is associated with B15 and C3, 
appears to have an earlier age of onset (Christy et al 1979), and to 
show an increased antibody response to exogenous insulin. It shows a 
stronger association with DW4 (Christy et al 1979; Rotter and Rimoin 
1978) and is not associated with autoimmune disease or persistence of 
islet cell antiboides. The presence of both B8-DW3/B15-DW14 is charac-
terised by an increased relative risk, i.e., the presence of both allelic 
groups confers an additive risk for developing the disease. 
In the present study a significant association between IDDM and B8 had 
been found in Indians only. The relative risk, which is 4,2, is 
higher than in European Caucasians. In African patients, although the 
relative risk due to B14 is 2,8, the increased frequency falls short of 
statistical significance. However there was a significant increase in 
the presence of either B8 and B14, which are cross-reacting antigens. 
It is probable that the same susceptibility gene is associated with 
either of these antigens in Africans. 
Neither the African patients nor the Indian patients with IDDM showed 
any increase in the frequencies of CW3, B15 and B18 as has been found 
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have been observed in Japanese (Kawa et al 1977; Nakao et al 1977; 
Wakisaka et al 1976) . Studies in American blacks have not shown any 
significant associations at the B locus (Duquesnoy et al 1979; Rodey 
et al 1979). Pate/1 et al (1977) did find an increased frequency of B8, 
but the corrected p value was not significant, as has been the case 
with the Afircan patients reported in this study. 
The negative correlation between B7 and IDDM shown in white Caucasians 
by Ludwig et al (1976) who combined data from several centres and by 
van de Putte et al (1976) in family studies was not seen in the African 
or Indian patients described here, and has also not been observed in 
American Blacks and Japanese. BW42 which has been detected only in 
black populations (Hammond et al 1980) appears to show a negative 
correlation with IDDM. It is difficult to gauge the significance of 
such a finding at present, since a decreased frequency of an antigen 
as opposed to an increased frequency requires a much larger sample 
size to become evident (Christy et al 1979). 
The close correlation between DR4 and IDDM seen in both the African 
and Indian patients has been observed in all the ethnic groups studied 
thus far (Svejgaard et al 1980). However an association with DR3 
could not be shown, unlike the findings in European Caucasians and 
American blacks. 
A significant negative.correlation between IDDM and HLA B7 or DR2 
which has been observed in white Caucasians was not seen in the African 
and Indian patients. In contrast a significant decrease in the fre-
quency of B7 has been observed in Indians of North India (Srikanta et 
al 1981). 
Studies in white Caucasians have thus far been unable to establish a 
significant relationship between NIDDM and HLA system in White Cauca-
sians (Christy et al 1979; Nelson and Pyke 1975). Other population 
groups, however, do show such associations. An increase in the fre-
quency of B35 has been shown in a small study involving South African 
Xhosas with NIDDM (Briggs et al 1980). In the Pima Indians with NIDDM 
an association with HLA-A2 has been shown, particularly in those with 
onset of disease under age 35 (Knowles et al 1981). 
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The clear association between NIDDM in young Indians and HLA BW61 shown 
in this study assumes particular significance when comparison is made 
with the findings of Serjeantson et al (1981), who also showed the 
same relationship in Fiji Indians with NIDDM- Since both the Fiji 
Indians and the Natal Indians have similar origins, the findings of 
identical HLA associations is not unexpected. 
Unlike Fiji Indians, Natal Indians do not show any linkage disequili-
brium between BW61 and AW24. In fact there was a high frequency of 
the latter in Indians with onset of IDDM before age 20, although the 
corrected p value fell short of statistical significance. 
This study has shown a clear association between diabetes mellitus and 
the HLA system in Africans and Indians. It has also served to high-
light differences in the specific allelic associations among various 
population groups. 
SUMMARY 
HLA A, B and C antigens were determined in 126 patients (70 Africans, 
56 Indians) with IDDM, 61 Indians with NIDDM, 14 patients initially 
presenting with NIDDM but later becoming insulin dependent, and 1 768 
(1 000 Africans, 768 Indians) controls. 30 Africans and 16 Indians 
with IDDM, and 118 African and 73 Indian controls were also typed for 
DR specificities. HLA DR4 was associated with IDDM in both races. 
In the African patients a relationship was seen between IDDM and the 
cross-reacting antigens B8 or B14. IDDM in Indians was associated 
with HLA B8, whereas NIDDM in the same race group showed a clear 
relationship with HLA BW61. 
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CHAPTER X 
IMMUNOLOGICAL ASPECTS OF IDDM IN 
YOUNG AFRICANS AND INDIANS 
INTRODUCTION 
The role of immunological factors in the aetiology of IDDM has aroused 
considerable interest in recent years. Although the association be-
tween IDDM and certain organ-specific autoimmune diseases had been known 
for some time, it was only after the demonstration by Bottazzo et al (1974) 
of islet cell antibodies in the sera of such patients that a direct 
line of evidence was produced supporting the part played by autoimmunity 
in the pathogenesis of the disease. Since then numerous studies have 
shown a high frequency of these antibodies in newly diagnosed cases of 
IDDM irrespective of whether other associated organ-specific autoimmune 
endocrinopathies were present or not, (Irvine 1977; Irvine et al 1980; 
Lendrum et al 1975; Lendrum et al 1976; Madsbad et al 1980; Keufeld et al 
1980). On the basis of these findings Cudworth (1978, 1980) was able 
to classify Type I diabetes (IDDM) into: 
a) Type 1a (the classical juvenile variant) in which ICA appears 
transiently at the onset of illness. 
b) Type 1b (the autoimmune variant) which is associated with thyroid, 
gastric and adrenal autoimmunity, the presence of HLA B8 and per-
sistence of ICA. 
Various types of ICA have been detected although they are all specifi-
cally directed at the islets of Langerhans. Complement-fixing islet 
cell antibodies (iCA-IgG) react with autoantigens present in the cyto-
plasm of the islet cells whereas islet cell surface antibodies (ICSA) 
are directed at the islet cell surface (Bottazzo and Doniach 1978; 
Bottazzo et al 1980; Lernmark et al 1978). 
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Since 1977 when increased levels of circulating immune complexes were 
reported for the first time in patients with IDDM (Irvine et al 1977) 
their significance as regards pathogenesis of the disease or its com-
plications has provoked much controversy which has as yet not been 
resolved. Like islet cell antibodies, immune complexes are found in 
high concentrations at the onset of IDDM and tend to disappear with 
time, (Irvine et al 1977; Irvine et al 1980a). Thus it may well be 
that islet cell-antibody reaction provides a substantial contribution 
to the presence of circulating immune complexes seen at the time of 
diagnosis (Irvine et al 1980). 
Although data on the prevalence of islet cell antibodies and immune 
complexes in populations other than white Caucasians are scanty, it 
does seem that American blacks and Japanese have a lower propensity to 
develop organ-specific autoimmunity s (Irvine -et al 1980b; Neufeld et-
al 1980.) 
PATIENTS AND METHODS 
Blood samples for islet cell antibodies, thyroid antibodies, parietal 
cell antibodies and adrenal antibodies were obtained from 44 African 
and 27 Indian patients with IDDM. They all formed part of the group 
of patients with IDDM described in Chapter II. The race, sex, and age 
distribition, together with the mean age of onset and the mean duration 
of disease are shown in Tables 1 and 2. 
In addition sera from 37 healthy controls (19 Africans, 18 Indians) were 
tested for these antibodies. 
Islet cell antibodies (ICA-IgG) were detected by indirect immunofluores-
cence in unfixed blood group 0 human pancreas obtained from cadaver 
kidney donors (Bottazzo at al 1981). 
Complement-fixing islet-cell antibodies (Cf-ICA) were assayed by the 
immunofluorescent complement-fixation test as described by Bottazzo 
et al (1981). 
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Key : 1. Islet Cell Antibodies 4. Thyroglobulin Haemagglutinating 
2. Complement-fixing Islet Cell Antibodies 
Antibodies. 5. Thyroid Microsomal Haemagglutinating 
3. Gastric Parietal Cell Antibodies. Antibodies 
6. Adrenal Antibodies. 
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KEY : Same as Table 1. 
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Thyroid microsomal haemagglutinating antibody, thyroglobulin haemag-
glutinating antibody, gastric parietal cell antibody and adrenal 
antibodies were determined by immunofluorescence using human tissue 
sections. 
Sera from immune complexes were obtained from 31 patients with IDDM 
(19 Africans and 12 Indians) and 29 healthy controls (19 Africans 
and 10 Indians). The age and sex distribution together with the mean 
age of onset and mean duration of disease are shown in Table 3. 
Immune complexes were determined by means of the Raji cell assay and 
the method used was Cunningham-Rundles et al's (1980> modification of 
the one described by Theofilopoulos et al (1976). 
RESULTS 
Results are shown in Tables 1 and 2. 
Islet Cell Antibodies 
Islet cell antibodies were detected in over a third of patients with 
IDDM, but in only 5% (2/37) of controls, the difference being highly 
significant (p < 0.005). 
Although the frequency of ICA's was slightly higher in the African 
patients (34% vs 30%) the difference was not significant. Similarly 
there was no significant difference in the frequencies of ICA's between 
males and females of both racial groups. 
ICA-IgG and ICA-Cf were found together in 10% of patients (5 Africans, 
2 Indians) but in none of the controls. Complement-fixing islet cell 
antibodies were found only in patients who were positive for ICA-IgG. 
They were not detected in any of the controls. 
The prevalence of ICA was significantly higher (30% vs 17%) in patients 
who had IDDM for less than a year than in those with a longer duration 
of disease (p < 0.025). Persistence of ICA beyond 3 years was signi-
ficantly more frequent in the African group*being found in almost 50% 
(10/21) of these patients and in only 1 (1/16) Indian patient, p < 0.025. 
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TABLE 3 CLINICAL CHARACTERISTICS OF THE PATIENTS WITH IDDM 
ON WHOM IMMUNE COMPLEXES WERE DONE. 
Number of patients 
M : F ratio 
Mean age in years (range) 
Mean duration of IDDM 
in years (range) 
Africans 
19 















Gastric Parietal Cell antibodies were detected in 13 patients with 
IDDM (18%) and in only 2 controls (5%), but the difference was not 
significant. 
Six patients (8%) had thyroid microsomal antibodies, whilst none of 
the controls was positive. They tended to be more common in Indian 
(4/27) than African (2/44) patients. Thyroglobulin haemagglutinating 
antibodies were detected in 1 patient and 1 control. 
None of the patients or controls showed the presence of adrenal auto-
antibodies. 
ICA and other autoantibodies were found together in 9 patients (12%) 
of whom 6 had IDDM for over a year. 
Immune Complexes 
The mean circulating immune complex levels in Afican patients and 
controls were 277 +_127jig/ml and 200^ 78yg/ml respectively. In the 
Indian patients and controls the values were 156 +_ 35 Ug/ml and 257 +_ 
35 Ug/ml respectively. 
Owing to a lack of an absolute standard of normal values, CIC levels 
below 100 Ug/ml are regarded as normal; 100 - 500 yg/ml as mild 
elevation; 501 - 1000 Ug/ml as moderate elevation and those above 
1 mg/ml as gross elevation (Pudifin and Duursma 1981). Among Africans 
immune complexes were found to be mildly elevated in 53% of patients 
and 68% of controls and normal in 47% of patients and 32% of controls. 
In the Indian group 83% of patients and 80% of controls had normal CIC 
levels, whereas mildly elevated levels were found in 17% and 20% 
respectively. 
None of the patients or controls had moderately elevated or grossly 
elevated CIC levels. 
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DISCUSSION 
Islet cell antibodies have been detected in up to 80% of white Cau-
casians with IDDM at the time of diagnosis. Thereafter their pre-
valence falls steadily, reaching 45% at one year and 25% at 2 years 
(Lendrum. et al 1976). In this study over 60% of the patients had ICA 
within 2 months of diagnosis and by one year the rate had fallen to 
30%, thus providing further support for the suggestion that the 
immunogenic parameters in blacks with IDDM are similar to those found 
in white Caucasians (Neufeld and Blizzard 1980). 
Studies in American blacks with a mean duration of IDDM of 3.2 years 
have shown an ICA prevalence rate of 22%, which was significantly 
lower than that found in white Caucasians (Neufeld et al 1980). In 
Natal African patients, however, the overall frequency is higher (34%), 
in spite of a similar mean duration of disease, and appears not to 
differ much from the 36% prevalence rate found in white Caucasians by 
Neufeld et al (1980). In addition, persistence of ICA beyond 3 years 
appears to be much more common in the Natal African diabetic patient 
(48%) than in his Indian (4%) or American counterpart (15%) (Neufeld 
et al 1980), although the fact that far more American blacks (53 vs 21) 
had a duration of disease falling in that range calls for caution in 
reaching any definite conclusions. 
In contrast ICA's have been found to be rare in Nigerian and Pima 
Indian diabetic subjects, even if assays were done at the time of 
diagnosis (Knowler et-al- 1979., Oli et al 1980). Such findings serve 
to highlight differences in the immunological aspects of the disease 
among the various population groups and to emphasise the heterogeneity 
of the disorder in blacks themselves. 
In this study the ICA frequency within 3 months of diagnosis of IDDM 
in Africans and Indians (29%) is similar to that reported in American 
blacks (33%), but considerably lower than the 74% rate found in white 
Caucasians (Christy et al 1977; Lendrum et al 1976; Neufeld et al 
1980). Thus it appears that ICA's persisting for longer than 3 months 
continue to do so for a long time in the Natal African. 
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The observation that only 48% of patients with ICA-IgG also had 
Cf-ICA is not surprising, as Bottazzo et al (1981) have also found 
a similar rate (50% - 55%). A likely explanation for this discrep-
ancy is that complement-fixing ICA tend to disappear sooner than 
ICA-IgG (Bottazzo et al 1981). The former type of ICA has also 
been found to be a better monitor of active beta cell damage 
(Bottazzo et al 1981). 
High frequencies of antibodies to thyroid, adrenal or gastric 
tissues in patients with IDDM have been shown in numerous studies 
(Bosteni and Gept 1-974; Christy et al 1977;Drash 1971) Irvine 
et al 1970; Neufeld et al 1980). Although the African and Indian 
patients reported in this study showed higher frequencies of 
parietal cell and thyroid antibodies compared to controls, none of 
them had adrenal antibodies. Neufeld et al (1980) also were unable 
to detect adrenal antibodies in American blacks, whilst finding 
increased frequencies of the other autoantibodies, which, however, 
were lower when compared to White Caucasians. Interestingly the 
4% prevalence rate for thyroid antibodies in American blacks 
(Neufeld et al 1980) was similar to that found in the Natal African. 
However, parietal cell antibodies were less common in the former 
group (10%) when compared to Africans (18%) or Indians (20%). 
Despite the small number of patients studied, the presence of 
parietal or thyroid antibodies appeared to be associated with ICA 
positive sera, particularly when the latter persisted beyond a year. 
The lack of significantly higher levels of circulating immune com-
plexes in African and Indian patients with IDDM may seem surprising 
in view of the relatively high frequency of islet cell antibodies, 
which have been shown to correlate with such complexes (Irvine et 
al 1980b) Several reasons could be advanced to explain this 
paradox. First and foremost is that the number of newly diagnosed 
diabetics studied were few and even in these cases sera were not 
taken in the first week of diagnosis, as had been done in Irvine's 
large series of 114 cases. In addition, circulating immune com-
plexes disappear earlier than ICA and are found only in about a 
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third of newlydiagnosed cases of IDDM (Bottazzo et al 1981). Thus 
the conclusion that CIC are not elevated in African and Indian 
patients with IDDM may not be valid. 
The findings in this study certainly support Neufeld and Blizzard's (1980) 
contention that immunological mechanisms similar to those in 
Caucasians play a part in the pathogenesis of IDDM in other race 
groups. However, whilst their conclusion that there is a lower 
propensity to organ-specific autoimmunity among blacks may apply 
to America, it may not be the case with the Natal African insulin-
dependent diabetic patient, in whom a relatively high frequency of 
persistent ICA has been found. 
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SUMMARY 
The presence or absence of islet cell antibodies and other autoanti-
bodies was determined in 44 African and 27 Indian patients with IDDM 
and 37 controls. Tests for immune complexes were done on 19 African 
and 12 Indian patients with IDDM, and 19 African and 10 Indian controls. 
Islet cell antibodies (ICA-IgG) were found in over a third of the 
patients and in only 2 controls. Complement fixing antibodies (ICA-Cf) 
were also found in 10% of patients, but in none of the controls, 
Persistence of ICA beyond 3 years was more frequent in African compared 
to Indian patients. Parietal cell and thyroid antibodies were found 
more often in patients than controls. None of the patients or controls 
had adrenal antibodies. Mild elevation of immune complex concentrations 
were found in both patients and controls with no significant difference 
between the 2 groups. Neither the patients nor the controls showed 
moderate or gross elevation of immune complex levels. 
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CHAPTER XI 
SUMMARY AND CONCLUSIONS 
In conclusion, this thesis set out to describe the patterns of diabetes 
mellitus in young Africans and Indians, identify differences between 
the racial groups and probe into the role of known aetiblogical factors 
in producing the disease in these populations. 
The data presented have described the pattern of IDDM and NIDDM in the 
2 groups. Thus both types of diabetes mellitus occur in each of the 
races, although the prevalence of IDDM is greater in Africans than 
Indians and that of NIDDM greater in the latter than the former. 
There are no distinctive features in the mode of onset, duration of 
disease and tendency to complications between the two groups, but 
interestingly the peak age of onset of IDDM tends to be later in 
Africans. Although Indians with the disease also show a later peak when 
compared to White Caucasians, the difference is not as pronounced as in 
Africans. It is difficult to ascribe a reason for such a difference, 
particularly when viewed against a background in which the aetiology 
of the disease remains obscure. Suffice it to say that if the same 
environmental factor is implicated in the aetiology of the disease in 
all population groups, Africans in particular appear to be protected 
at an age when susceptibility is greatest in White Caucasians. 
The demonstration of a significant association between IDDM and the 
HLA system in both Africans and Indians highlights the importance of 
genetic susceptibility to the disease, as has been observed in numerous 
studies on White Caucasians. This study also confirms the existence 
of ethnic variability in the specific allelic associations of the 
disease. Thus, as in Whites HLA B8 is a significant risk factor for 
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IDDM among Indians whereas the same is not true for Africans. The 
presence of DR4, which has been associated with IDDM in Whites, also 
confers increased susceptibility to the disease in Africans and 
Indians. » 
The association between HLA BW61 and NIDDM in young Indians, although 
an unexpected finding, serves to emphasise the heterogenous nature of 
the disease because as yet no such relationship has been observed in 
white Caucasians (Christy et al 1979; Nelson and Pyke 1975). 
The high prevalence of NIDDM in first degree relatives of young patients 
with this disease suggests an autosomal dominant mode of inheritance, 
as shown in studies on similar patients elsewhere (Fajans et al 1978; 
Tattersall 1974) . 
IDDM in young Indians was also associated with a relatively strong 
family history of NIDDM in first degree relatives. Whether it reflects 
the high prevalence of NIDDM in the population group (West 1978) or 
whether some aetiological role could be ascribed to it is difficult 
to determine. However, it certainly represents a unique finding. 
The presence of islet cell antibodies in a fair proportion of African 
and Indian patients with IDDM,in spite of the relatively long time after 
onset of the disease that specimens were taken, serves to highlight the 
important role played by autoimmunity in the pathogenesis of IDDM in 
both population groups. 
NIDDM in young Indians shows certain distinct differences from the 
classical descriptions of the disease by Fajans et al (1976) and 
Tattersall (1974). Obesity is much more common and complications are 
by no means rare in patients reported in this study. Thus the disease 
in this population group is more akin to the typical NIDDM of the 
middle aged and elderly. 
Chronic complications of the disease appear to be related to duration 
of diabetes in both population groups. Similar findings have been 
documented in numerous studies (West 1978). 
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Ketoacidotic coma, however, was much more common in patients reported 
in this study, often being due to omission of insulin. Lack of primary 
health care facilities, inadequate education and poor socio-economic 
conditions appear to be primarily responsible for such a high prevalence 
of this complication. 
This study has served to highlight the poor state of metabolic control 
in most of the insulin-dependent diabetic patients. Once again the 
inadequate social and education circumstances appear to play a major 
role for this state of affairs. Hence better education of the patients 
and the provision of more primary health care facilities should occupy 
top priority. 
Although the hormonal pattern shows no striking differences when 
compared to the disease patterns seen elsewhere, there are certain 
racial differences. Thus insulin and C-peptide repsonses are lower 
in Africans withNIDDM and IDDM, suggesting a greater degree of beta cell 
destruction in these patients. 
The relatively high insulin requirements found in Africans and Indians 
with IDDM represent a feature of the disease that is commonly seen in 
J-type diabetes mellitus. However, the tendency to ketosis characteris-
tic of IDDM in both population groups is a distinct difference that 
makes it more akin to the disease as seen in temperate climates. 
NIDDM in young Africans and Indians also has been shown to be quite 
distinct from J-type diabetes, in that obesity is quite common and 
control could be easily achieved by means of diet with or without oral 
hypoglycaemic agents, in contrast to the leanness and high insulin 
requirements characteristic of J-type diabetes. 
The rarity of J-type diabetes and virtual absence of Z-type diabetes in 
both Africans and Indians is somewhat surprising, because both varieties 
of tropical diabetes are common in India and other parts of Africa. 
Judging by the high prevalence of kwashiokor in South Africa (Davel 
1965, Schlemmer and Stopforth 1974), there is little doubt that mal-
nutrition is rife. Since tropical diabetes is generally associated with 
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malnutrition, the disease would be expected to be common here, but 
this is not borne out by the results of this study. A possible ex-
planation for this anomaly is that some other environmental factor 
peculiar to the areas of high prevalence of the disease, e.g. cassava 
consumption (McMillan and Geevarghese 1979) plays a part in its patho-
genesis. This may also account for its virtual absence among Indians, 
although the hypothesis that the state of nutrition of young Indians, 
being better than that of their cousins in India, acts as a protective 
mechanism also sounds reasonable. 
The data presented, it is hoped, have more than covered the scope of the 
thesis. They have served to show that diabetes mellitus affecting young 
Africans and Indians in Natal is similar to the disease seen in temperate 
climates and no less heterogenous in its appearance. This study has 
been instrumental in highlighting the role of known aetiological factors 
elsewhere as being of equal importance in the pathogenesis of the 
disease in the local populations. It has also helped to raise more 
questions than could be answered, namely,questions on the association 
between the HLA system and NIDDM, the high prevalence of NIDDM in first 
degree relatives of Indian patients with IDDM, and the later peak in 
age of onset of IDDM in Africans. 
Further studies will undoubtedly have to be undertaken to define and 
evaluate the role of these and other factors in the pathogenesis of 
IDDM and NIDDM in Africans and Indians in Natal. 
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APPENDIX 
Dete rmina t ion of Plasma C-Pept ide C o n c e n t r a t i o n s . 
This was assayed by radioimmunoassay us ing a Byk-Mal l inckrodt RIA-mat 
C-Pept ide k i t . (Rad iopha rmazeu t ika -Diagnos t i ca ) . 
Reagents 
l . 1 2 ^ - C - P e p t i d e . 
2 . C-Pept ide s t a n d a r d s . 
3 . Rabbit a n t i - C - p e p t i d e serum. 
4 . Goat a n t i - r a b b i t - g a m m a - g l o b u l i n . 
5 . Cont ro l serum. 
Method 
1. 0.1 ml of C-peptide standards, test sera and control sera were 
pipetted into appropriate test tubes, each one being done in 
duplicate. 
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2. 0.1 ml I-C-peptide was added to each test tube. 
3. 0.1 ml C-peptide antiserum was then added to each tube, mixed well 
and covered with Parafilm. 
4. The test tubes were incubated at 4 C for 48 hours. 
5. 0.5 ml goat anti-serum (reconstituted just before use) was added 
to each test tube and mixed well. 
6. The tubes were incubated at 4 C for 24 hours. 
7. They were then centrifuged for 30 minutes at 2000g. 
8. The supernatant in each tube was aspirated. 
9. The radioactivity in each tube was determined using a gammacounter. 
10. The count rate for each standard was expressed as a percentage of 
the mean rate of the zeros and a standard curve constructed plotting 
these values against the concentration of the C-peptide. The count 
rates of the test sera were also expressed as percentages of the 
mean count rate of the zeros and the resulting values used to read 
off the C-peptide concentrations from the standard curve. 
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Modified Method 
Byk-Mallinckrodt Radiopharmazeutika-Diagnostica introduced a slight 
modification of the original method in their kits from April, 1981. 
In these kits the reagents were identical. The changes in the 
methodology involved:-
a. Step 4 (above), where incubation was only done for 24 hours at 
25 C instead of for 48 hours. 
b. Step 6 (above), where the tubes were now incubated for 30 minutes 
only at 25 C, instead of for 24 hours. 
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APPENDIX B 
Determination of Plasma Insulin Concentrations. 
Insulin was assayed by radioimmunoassay, using Pharmacias Phadebas 
Insulin Test Kits. 
Reagents 
1. Sephadex-Anti-Insulin complex, antibodies rasied in guinea pigs. 
2. Insulin standard 320 yU/ml after reconstitution. 
125 
3. Insulin I 8ng - 3 pCl. 
4. Buffer subtance 42 gm dry powder. 
Method 
1. Insulin standard solution was diluted with buffer solution in order 
to obtain suitable concentrations within the range 3 - 320 yU/ml. 
Buffer was used as zero sample. 
2. 0.1 ml of standard (of varying dilutions ranging from 0 - 320 yU/ml) 
were pipetted, each one in duplicate, into siliconized glass centri-
fuged tubes with round bottoms. 
3. 0.1 ml of the test sera were pipetted each one in duplicate into 
similar tubes. 
125 
4. 0.1 ml of the Insulin I were then pipetted into each of the 
tubes mentioned in (2) and (3). 
125 
5. 0.1 ml of the Insulin I were pipetted into 2 tubes which were 
then stoppered immediately. These were used to determine the 
total activity and were therefore not incubated, centrifuged or 
washed. 
6. 1 ml sephadex-Anti-Insulin Complex suspension was pipetted into 
each of the tubes mentioned in (2) and (3). 
7. The tubes were then incubated for 3 hours in a shaker. 
8. The tubes mentioned in (2) and (3) were then centrifuged twice and 
the supernatant aspirated. 
9. They were then washed by adding 2 ml 0.9% saline and centrifuged, 
and the supernatant aspirated. The washing procedure was done 
thrice. 
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10. The radioactivity was determined in all the tubes using a gamma-
counter. 
11. The count rate for each of the standards was expressed as a per-
centage of the mean count rate of the zeros. A standard curve 
was contructed plotting the percentage values obtained for the 
standards against the logarithm of insulin concentrations. 
The count rate for each of the test samples was also expressed as 
a percentage of the mean count rate of the zeros and from the 
values obtained the concentrations of insulin were read off 
directly from the curve. 
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APPENDIX 
Determination of Plasma Glucagon Concentrations. 
Glucagon was assayed by radioimmunoassay using Biodata Glucagon Kits. 
Reagents 
1. Anti-Glucagon serum. 
2. Glucagon standard 2 000 pg/ml after reconstitution. 
* 1 2 5 T PI 
3. I-Glucagon. 
4. Polyethylenglycol solution. 
5. Trasylol. 
6. Buffer. 
7. Carrier serum. 
Method 
1. Four groups of tubes are prepared, representing zero (cold hormone) 
concentrations); controls; glucagon standards; and sample tubes. 
2. 0.1 ml Trasylol was added to all the tubes. 
3. 0.1 ml antiglucagon serum was then added to the standard, sample 
and zero tubes. 
4. All the tubes were then incubated at 4 C for 24 hours. 
125 
5. 0.1 ml I-Glucagon was added to all the tubes and the contents 
mixed. 
6. The tubes were then incubated at 4 C for 24 hours. 
7. 0.1 ml Carrier serum was added to all the tubes and the contents 
mixed. 
8. The total counts of the zero tubes were determined. 
9. 1 ml polyethylenglycol solution was then added to all the tubes 
and the contents mixed by Vortex. 
10. All the tubes were centrifuged at 3 000 g for 15 minutes. 
11. The supernatant was decanted and the precipitate washed by adding 
2 ml distilled water to each tube. 
12. The tubes were centrifuged again at 1 500 - 3 000 g for 2 - 3 
minutes. 
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The supernatant was decanted and the tubes left inverted on a sheet 
of filter paper. 
The radioactivity in all the tubes was now counted for at least a 
minute. 
The percentage binding in absence of unlabelled hormone (maximum 
binding) is obtained using the mean c.p.m. bound in the zero tubes:-
Mean c.p.m. bound in zero tubes 
X 100 = % binding 
Total radioactivity 
The inhibition percentage for each standard ans sample level was 
then calculated by expressing the mean c.p.m. in these tubes as 
a percentage of the mean c.p.m. in the zero tubes. By plotting 
the % inhibition against the different standard concentrations, 
the standard curve was obtained. The % inhibition values of the 
sample tubes were then used to read off the hormone concentrations 
from the standard curve. 
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APPENDIX D 
Determination of Plasma Growth Hormone Concentrations. 
Plasma growth hormone levels were assayed by radioimmunoassay , using 
Phadebas Kits (Pharmacia Diagnostics. 
Reagents 
1. Human Growth Hormone (hGh) standard. 
125 
2. Anti hGH I (antibodies raised in rabbits). 
3. Anti-hGH discs (antibodies raised in sheep). 
4. hGH-free diluent (horse serum). 
Method 
1. 3 groups of tubes are prepared (each tube in duplicate), repre-
senting total activity, standards, and samples. 
2. One Anti-hGH disc is added to the bottom of all tubes except the 
total activity ones. 
3. 100 yl of each standard is pipetted in duplicate onto the discs in 
the standard tubes. 
4. 100 yl of the sample sera are pipetted in duplicate onto the discs 
in the sample tubes. 
5. The tubes are covered with plastic film and incubated for 3 hours 
at room temperature. 
6. The supernatant from each tube is decanted and 2.5 ml saline added 
to all the tubes except the total activity tubes. Each tube is 
allowed to stand for 10 minutes. This procedure is repeated twice. 
125 
7. 100 yl of the anti-hGH I solution is pipetted into the bottom of 
all tubes. 
8. The total activity tubes are capped and set aside, whilst the other 
tubes are covered with plastic and incubated overnight at room 
temperature. 
9. The supernatant in each tube is decanted. 
10. 2.5 ml saline is added and the tubes allowed to stand for 10 
minutes. All the liquid is again aspirated and the rinsing procedure 
repeated twice. 
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The tubes are capped and the radioactivity determined in all of 
them including the total activity tubes for 1 minute. 
The count for each of the standards and unknowns is expressed as a 
percentage of the mean count of total activity. A standard curve 
is obtained by plotting the percentage values of the standards 
against the hGH concentrations. The growth hormone concentrations 
of the samples are then read off from the graph. 
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APPENDIX E 
Determination of Plasma Cortisol Concentrations. 
Plasma Cortisol levels were done by radioimmunoassay, using Gamma-Coat 
Kits (Travenol Laboratories). 
Reagents 
125 
1. I Cortisol Tracer. 
2. Rabbit anti-cortisol serum coated tubes. 
3. Phosphate buffered saline. 
4. Processed human serum (blank). 
5. Cortisol serum standards. 
Method 
1. 4 groups of Gamma Coat tubes are prepared, (each tube in duplicate), 
representing the Total Counts; the blanks, the standards and the 
samples. 
2. 1 ml of.Tracer-Buffer Reagant is added to each tube and the 
contents mixed. 
3. The tubes are incubated in a water birth for 45 minutes at 37 C. 
4. All the tubes, except the Total Counts, are then decanted. 
5. The radioactivity in each tube is then determined for one minute. 
6. A standard curve is drawn by plotting the CPM Bound for the Cortisol 
concentrations. The CPM Bound for the samples are used to read off 
the concentrations from the standard curve. 
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APPENDIX F 
Determination of Islet-Cell Antibodies. 
Islet cell antibodies were detected by a standard indirect immuno-
fluorescent method. 
A. Islet Cell Antibodies (ICA-IgG) 
Reagents 
1. Human pancrease-obtained from group 0 cadaver kidney donor. 
2. Anti-IgG Fluorescine Isothiocyanate Conjugate (FITC). 
Method 
1. The patient's serum is applied for 30 minutes at room temperature 
to the pancreas sections. 
2. Specific anti-IgG FITC conjugate is then added. 
3. The section is observed for immunofluorescence using an ultra-
violet microscope equipped with epi-illumination. 
B. Complement-Fixing Islet-Cell Antibodies (Cf-ICA) 
Reagents 
1. Human pancrease - obtained from group 0 cadaver kidney donor. 
2. Fresh normal human serum. 
3. Anti-human C3 conjugate. 
Method 
1. The patient's serum is applied for 30 minutes at room temperature 
to the pancreas sections. 
2. After washing, a drop of fresh human normal serum is applied as a 
source of complement. 
3. Anti-human C3 conjugate is then added. 
4. The section is observed for immunofluorescence as above. 
189 
APPENDIX 
Determination of Circulating Immune Complexes. 









.05% Tween 20 in saline. 
Anti-human IgG. 
Nitrophenyl phosphate solution. 
5. 10% sodium hydroxide. 
Method 
1. Raji cells propagated in RPMI 1 640 + 10% fetal calf serum are 
washed 3 times, counted and resuspended in medium at a cell con-
centration of 40 000/yl. 
2. 25 Ul of a l-in-4 dilution of test serum in saline is added to .50 
yl of the Raji cell suspension. 
3. The mixture is incubated at 37 C for 30 minutes. 
4. The cell pellet is then washed 3 times in saline containing 0.05% 
Tween 20. 
5. An enzyme-linked immunosorbent assay is then used to detect IgG 
adhering to the surface of the cells. 
6. 1 ml of rabbit anti-human IgG (previously conjugated with alkaline 
phosphate is added). 
7. The mixture is incubated at 37 C for 2 hours and then washed 
thriced in saline-Tween 20. 
8. 1 ml nitrophenyl phosphate solution is then added to the disag-
gregated pellet of Raji cells. 
9. Colour change is allowed to proceed until a fairly deep yellow is 
observed in the high reading control tube. 
10. The reaction is stopped by adding 100 yl of 10% sodium hydroxide. 
11. The tubes are centrifuged and the supernatant decanted for reading 
in a spectrophotometer at 400 mm. 
The results are quantitated by means of a standard curve made 
each day using serial dilutions of an aliquot of serum (from a 
patient with systemic lupus erythematous) which has been stan-
dardized against a known concentration of aggregated IgG. High-




List of abbreviations used 
ADA Adrenal Antibodies 
CIC Circulating Immune Complexes 
GPC Gastric Parietal Cell Antibodies 
GTT Glucose Tolerance Test 
HbA1 Glycosylated Haemoglobin 
IBW Ideal Body Weight 
ICA IgG Islet Cell Antibodies 
ICA - cf Complement-fixing Islet Cell Antibodies 
IDDM Insulin-dependent Diabetes Mellitus 
IU/L International Units per litre 
JOD Juvenile-onset Diabetes Mellitus 
MCHA Thyroid Microsomal Haemagglutinating Antibody 
MMOL/£ Millimoles per litre 
MOD Maturity-onset type Diabetes Mellitus 
MODY Maturity-onset type Diabetes Mellitus of the Young 
NIDDM Non-insulin-dependent Diabetes Mellitus 
nmoles/£ Nanomoles per litre 
pg/m£ Picograms per millilitre 
Uu/m£ Microunits per millilitre 
TGHA Thyroglobulin Haemagglutinating Antibody 
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ADDENDUM I 
A survey of African diabetic patients was done at the outpatient's 
department of King Edward VIII Hospital (Durban), whilst surveys of 
Indian patients were carried out at the outpatient's department of 
RK Khan Hospital (Durban) and at the Beatrice Street Clinic (Durban). 
The clinical case records of all diabetic patients seen at these 
centres over a four-week period were scrutinised in order to determine 
their ages and types of diabetes. The results were are follows: 
Africans 
Total No. of Patients 247 
Patients with IDDM 21 
Patients with NIDDM 226 
Patients under age 35 25 
Patients under 35 with IDDM 21 









Oral Hypoglycaemic Therapy in Patients with NIDDM 
Africans 
Diet 
Diet + Tolbutamide 2 
Diet + Chlorproamide 9 
Diet + Glibenclamide 2 
Diet + Phenformin 
Diet + Phenformin + , 
Chlorpropamide 
Diet + Phenformin + 1 
Glibenclamide 
Indians 
3 
3 
21 
17 
2 
11 
4 
